{"clause_number": "Clause 1", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. The Holder may notify the Company in an Exercise Notice of its election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant Units determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the daily volume weighted average price for the Common Stock for the five Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/fathom-holdings-inc-10092/contract/108376/#clause-id-201548", "variations": [{"variation_number": "Variation 1", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. The Holder may notify the Company in an Exercise Notice of its election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant Units determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the daily volume weighted average price for the Common Stock for the five Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/fathom-holdings-inc-10092/contract/108376/#clause-id-201548"}, {"variation_number": "Variation 2", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. <del>The</del>  <ins>Notwithstanding anything contained herein to the contrary, if at the time of exercise hereof the Registration Statement is not effective (or the prospectus contained therein is not available for use) for the issuance of all of the Warrant Shares, then the</ins> Holder <del>may notify</del>  <ins>may, in its sole discretion, exercise this Warrant in whole or in part and, in lieu of making the cash payment otherwise contemplated to be made to</ins> the Company <ins>upon such exercise</ins> in <del>an</del>  <ins>payment of the Aggregate</ins> Exercise <del>Notice</del>  <ins>Price, elect instead to receive upon such exercise the \"Net Number\"</ins> of <del>its election to utilize cashless exercise, in which event the Company shall issue</del>  <ins>Warrant Shares determined according</ins> to the <del>Holder the number of Warrant Units determined as follows:</del>  <ins>following formula (a \"Cashless Exercise\"):</ins> X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the <del>daily volume weighted average price for the Common Stock</del>  <ins>Closing Prices</ins> for the five Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/marathon-patent-group-inc-3958/contract/353451/#clause-id-768743"}, {"variation_number": "Variation 3", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver <ins>the Exercise Price in the form of a check payable to American Stock Transfer & Trust Company LLC, or by wire transfer of</ins> immediately available <del>funds;</del>  <ins>funds to an account designated by the Warrant Agent;</ins> or (b) Cashless Exercise. <del>The</del>  <ins>At a time when a registration statement permitting the Holder to resell the Warrant Shares is not then effective or the prospectus forming a part thereof is not then available to the Holder for the resale of the Warrant Shares, then the</ins> Holder may <del>notify the Company in</del>  <ins>deliver</ins> an Exercise Notice <ins>to the Company at the address set forth in Section 13</ins> of its election to utilize <ins>a</ins> cashless exercise, in which event the Company shall issue to the Holder the number of Warrant <del>Units</del>  <ins>Shares</ins> determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which <del>this</del>  <ins>the</ins> Warrant is being exercised. A = the average of the <del>daily volume weighted average price for the Common Stock</del>  <ins>Closing Prices</ins> for the five Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date <del>this</del>  <ins>the</ins> Warrant was originally issued. <ins>(c) Disposition of Proceeds on Exercise of Warrants. The Warrant Agent shall promptly forward to the Company all monies received by the Warrant Agent for the purchase of shares of Common Stock through the exercise of Warrants.</ins>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/crossroads-systems-inc-18362/contract/395785/#clause-id-842961"}, {"variation_number": "Variation 4", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. <del>The</del>  <ins>In lieu of a cash exercise pursuant to Section 10(a), the</ins> Holder may notify the Company in an Exercise Notice of its election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant <del>Units</del>  <ins>Shares</ins> determined as <del>follows:</del>  <ins>follows (it being acknowledged, for the avoidance of doubt, t hat such Warrant Shares will be unregistered): 6</ins> X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the daily volume weighted average price <del>for</del>  <ins>of</ins> the Common Stock for the five Trading Days immediately prior to (but not including) the <del>Exercise Date.</del>  <ins>Date of Exercise.</ins> B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued. <ins>For the avoidance of doubt, there is no circumstance that would require the Company to net cash settle the Warrant.</ins>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/delmar-pharmaceuticals-inc-3882/contract/356148/#clause-id-775924"}, {"variation_number": "Variation 5", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. <del>The Holder</del>  <ins>If at any time after the six-month anniversary of the issue date, there is no effective registration statement registering, or no current prospectus available for the resale of the Warrant shares by the Holder, then this Warrant</ins> may <del>notify the Company</del>  <ins>also be exercised,</ins> in <del>an Exercise Notice</del>  <ins>whole or in part, at such ti me by means</ins> of <del>its election to utilize cashless exercise,</del>  <ins>a \"cashless exercise\"</ins> in which <del>event the Company shall issue to</del> the Holder <del>the</del>  <ins>shall be entitled to receive a</ins> number of Warrant <del>Units determined as follows:</del>  <ins>shares equal:</ins> X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the <del>daily volume weighted average price for the Common Stock</del>  <ins>Closing Prices</ins> for the five Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/monaker-group-inc-3067/contract/501535/#clause-id-1128268"}, {"variation_number": "Variation 6", "text": "Payment of Exercise Price. The Holder <del>may</del>  <ins>shall</ins> pay the Exercise Price in <del>one of</del>  <ins>immediately available funds or,</ins> the <del>following manners: (a) Cash Exercise. The</del> Holder may <del>deliver immediately available funds; or (b) Cashless Exercise. The Holder may notify</del>  <ins>satisfy its obligation to pay</ins> the <del>Company in an</del> Exercise <del>Notice of its election to utilize cashless exercise,</del>  <ins>Price through a \"cashless exercise,\"</ins> in which event the Company shall issue to the Holder the number of Warrant <del>Units</del>  <ins>Shares</ins> determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the <ins>arithmetic</ins> average of the <del>daily volume weighted average price</del>  <ins>VWAP</ins> for the <del>Common Stock for the five</del>  <ins>twenty</ins> Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally <del>issued.</del>  <ins>issued pursuant to the Purchase Agreement.</ins>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/sibling-group-holdings-inc-19530/contract/480749/#clause-id-1076073"}, {"variation_number": "Variation 7", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. <del>The</del>  <ins>If an Exercise Notice is delivered at a time when a registration statement permitting the Holder to resell the Warrant Shares is not then effective or the prospectus forming a part thereof is not then available to the Holder for the resale of the Warrant Shares, then the</ins> Holder may <ins>5</ins> notify the Company in an Exercise Notice ofits election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant <del>Units</del>  <ins>Shares</ins> determined as follows: X = Y <del>[(A-B)/A]</del>  <ins>\u00d7 (A \u2013 B) A</ins> where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the <del>average of the daily volume weighted average price for the Common Stock for the five Trading Days immediately prior to (but not including) the Exercise Date.</del>  <ins>Closing Price.</ins> B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/sun-biopharma-inc-1655/contract/121149/#clause-id-227129"}, {"variation_number": "Variation 8", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. <del>The</del>  <ins>If an Exercise Notice is delivered at a time when a registration statement permitting the Holder to resell the Warrant Shares is not then effective or the prospectus forming a part thereof is not then available to the Holder for the resale of the Warrant Shares, then the</ins> Holder may notify the <del>Company</del>  <ins>Warrant Agent</ins> in an Exercise Notice of its election to utilize <ins>a</ins> cashless exercise, in which event the Company shall issue to the Holder the number of Warrant <del>Units</del>  <ins>Shares</ins> determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which <del>this</del>  <ins>the</ins> Warrant is being exercised. A = the average of the <del>daily volume weighted average price for the Common Stock</del>  <ins>Closing Prices</ins> for the five Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date <del>this</del>  <ins>the</ins> Warrant was originally issued. <ins>(c) Disposition of Proceeds on Exercise of Warrants. The Warrant Agent shall promptly forward to the Company all monies received by the Warrant Agent for the purchase of shares of Common Stock through the exercise of Warrants.</ins>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/nxt-id-inc-4396/contract/459934/#clause-id-1023578"}, {"variation_number": "Variation 9", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. <del>The</del>  <ins>If an Exercise Notice is delivered at a time when a registration statement permitting the Holder to resell the Warrant Shares is not then effective or the prospectus forming a part thereof is not then available to the Holder for the resale of the Warrant Shares, then the</ins> Holder may <ins>5</ins> notify the Company in an Exercise Notice ofits election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant <del>Units</del>  <ins>Shares</ins> determined as follows: <del>X = Y [(A-B)/A]</del> where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the <del>average of the daily volume weighted average price for the Common Stock for the five Trading Days immediately prior to (but not including) the Exercise Date.</del>  <ins>Closing Price.</ins> B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/sun-biopharma-inc-1655/contract/69177/#clause-id-127409"}, {"variation_number": "Variation 10", "text": "Payment of Exercise Price. The Holder <del>may</del>  <ins>shall</ins> pay the Exercise Price in <del>one of the following manners: (a) Cash Exercise. The Holder may deliver</del> immediately available funds; <del>or (b) Cashless Exercise. The Holder</del>  <ins>provided, however, the Holder, in its sole discretion,</ins> may <del>notify</del>  <ins>also satisfy its obligation to pay</ins> the <del>Company in an</del> Exercise <del>Notice of its election to utilize cashless exercise,</del>  <ins>Price through a \"cashless exercise,\"</ins> in which event the Company shall issue to the Holder the number of Warrant <del>Units</del>  <ins>Shares</ins> determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the <del>daily volume weighted average price for the Common Stock</del>  <ins>Closing Prices</ins> for the five Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/isign-solutions-inc-8751/contract/445102/#clause-id-983634"}, {"variation_number": "Variation 11", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. The Holder may notify the Company in an Exercise Notice of its election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant Units determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the daily volume weighted average price for the Common Stock for the five Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/fathom-holdings-inc-10092/contract/108376/#clause-id-201548"}, {"variation_number": "Variation 12", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. <del>The</del>  <ins>Pursuant to a Company Exercise, or if an Exercise Notice is delivered at a time when a registration statement permitting the Holder to resell the Warrant Shares is not then effective or the prospectus forming a part thereof is not then available to the Holder for the resale of the Warrant Shares, then the</ins> Holder may notify theCompany in an Exercise Notice of its election to utilize <ins>a</ins> cashless exercise, in which event the Company shall issue to the Holder the number of Warrant <del>Units</del>  <ins>Shares</ins> determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the <del>daily volume weighted average price for the Common Stock</del>  <ins>Closing Prices</ins> for the five Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise Price. <ins>Placement Agency Agreement (PIPE)Attachment I</ins> For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/akoustis-technologies-inc-4579/contract/498183/#clause-id-1121010"}, {"variation_number": "Variation 13", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. <del>The</del>  <ins>If on the Date of Exercise there is no effective registration statement registering, or the prospectus contained therein is not available for, the resale of the Warrant Securities, the</ins> Holder may notify the Company in an Exercise Notice of its election to utilize cashless exercise, in which event the Company shall issue to theHolder the number of Warrant <del>Units</del>  <ins>Securities</ins> determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant <del>Shares</del>  <ins>Securities</ins> to be issued to the Holder. Y = the number of Warrant <del>Shares</del>  <ins>Securities</ins> with respect to which this Warrant is being exercised. A = the average of the daily volume weighted average price <del>for</del>  <ins>of</ins> the Common Stock for the five Trading Days immediately prior to (but not including) the <del>Exercise Date.</del>  <ins>Date of Exercise.</ins> B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant <del>Shares</del>  <ins>Securities</ins> issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant <del>Shares</del>  <ins>Securities</ins> shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/applied-dna-sciences-inc-7031/contract/478635/#clause-id-1070331"}, {"variation_number": "Variation 14", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: <del>(a) Cash</del>  <ins>(a)Cash</ins> Exercise. The Holder may deliver immediately available funds; or <del>(b) Cashless</del>  <ins>(b)Cashless</ins> Exercise. <del>The Holder</del>  <ins>If at the time of exercise hereof there is no effective registration statement registering, or no current prospectus available for, the issuance or resale of the Warrant Shares by the Holder, then this Warrant</ins> may <del>notify the Company</del>  <ins>also be exercised,</ins> in <del>an Exercise Notice</del>  <ins>whole or in part, at such t ime by means</ins> of <del>its election to utilize cashless exercise,</del>  <ins>a \"cashless exercise\"</ins> in which <del>event the Company shall issue to</del> the Holder <del>the</del>  <ins>shall be entitled to receive a</ins> number of Warrant <del>Units</del>  <ins>Shares</ins> determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the daily volume weighted average price for the Common Stock for the five Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/achieve-life-sciences-inc-7894/contract/140790/#clause-id-275144"}, {"variation_number": "Variation 15", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or <ins>8</ins> (b) Cashless Exercise. <del>The</del>  <ins>If an Exercise Notice is delivered at a time when a registration statement permitting the Holder to resell the Warrant Shares is not then effective or the prospectus forming a part thereof is not then available to the Holder for the resale of the Warrant Shares, then the</ins> Holder may notify the Company in an Exercise Notice ofits election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant <del>Units</del>  <ins>Shares</ins> determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the <del>daily volume weighted average price for the Common Stock</del>  <ins>closing prices</ins> for the five Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/duos-technologies-group-inc-3224/contract/350162/#clause-id-760842"}, {"variation_number": "Variation 16", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. <del>The</del>  <ins>If an Exercise Notice is delivered at a time when a registration statement permitting the Holder to resell the Warrant Shares is not then effective or the prospectus forming a part thereof is not then available to the Holder for the resale of the Warrant Shares, then the</ins> Holder may notify the Company in an Exercise Notice of its election to utilize <ins>a</ins> cashless exercise, in which event the Company shall issue to the Holder the number of Warrant <del>Units</del>  <ins>Shares</ins> determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the <del>daily volume weighted average price for the Common Stock</del>  <ins>Closing Prices</ins> for the five Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/xtant-medical-holdings-inc-3605/contract/419042/#clause-id-906194"}, {"variation_number": "Variation 17", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. <del>The</del>  <ins>If an Exercise Notice is delivered at a time when a registration statement permitting the Holder to resell the Warrant Shares is not then effective or the prospectus forming a part thereof is not then available to the Holder for the resale of the Warrant Shares, then the</ins> Holder may notify the Company in an Exercise Notice of its election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant <del>Units</del>  <ins>Shares</ins> determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the <del>daily volume weighted average price for the Common Stock</del>  <ins>Closing Prices</ins> for the five Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/vertex-energy-inc-7596/contract/389887/#clause-id-828276"}, {"variation_number": "Variation 18", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. <del>The</del>  <ins>If on the Date of Exercise there is no effective registration statement registering, or the prospectus contained therein is not available for, the resale of the Warrant Shares, the</ins> Holder may notify the Company in an Exercise Notice of its election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant <del>Units</del>  <ins>Shares</ins> determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. <ins>-7-</ins> A = the average of the daily volume weighted average price <del>for</del>  <ins>of</ins> the Common Stock for the five Trading Days immediately prior to (but not including) the <del>Exercise Date.</del>  <ins>Date of Exercise.</ins> B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/soleno-therapeutics-inc-3774/contract/421686/#clause-id-914831"}, {"variation_number": "Variation 19", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. <del>The</del>  <ins>If on the Date of Exercise there is no effective registration statement registering, or the prospectus contained therein is not available for, the resale of the Warrant Shares, the</ins> Holder may notify the Company in an Exercise Notice of its election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant <del>Units</del>  <ins>Shares</ins> determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the daily volume weighted average price <del>for</del>  <ins>of</ins> the Common Stock for the five Trading Days immediately prior to (but not including) the <del>Exercise Date.</del>  <ins>Date of Exercise.</ins> B = the Exercise Price. <ins>7</ins> For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/applied-dna-sciences-inc-7031/contract/457831/#clause-id-1017848"}, {"variation_number": "Variation 20", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. <del>The</del>  <ins>If on the Date of Exercise there is no effective registration statement registering, or the prospectus contained therein is not available for, the resale of the Warrant Shares, the</ins> Holder may notify the Company in an Exercise Notice of its election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant <del>Units</del>  <ins>Shares</ins> determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the daily volume weighted average price <del>for</del>  <ins>of</ins> the Common Stock for the five Trading Days immediately prior to (but not including) the <del>Exercise Date.</del>  <ins>Date of Exercise.</ins> B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/mynd-analytics-inc-7289/contract/522351/#clause-id-1182036"}]}
{"clause_number": "Clause 2", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless exercise\", in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, as determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale Prices of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). In the event that a registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10. Except as set forth in Section 5(b) (Buy-In remedy) and Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/aquinox-pharmaceuticals-inc-3280/contract/80646/#clause-id-152713", "variations": [{"variation_number": "Variation 1", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless exercise\", in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, as determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale Prices of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). In the event that a registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10. Except as set forth in Section 5(b) (Buy-In remedy) and Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/aquinox-pharmaceuticals-inc-3280/contract/80646/#clause-id-152713"}, {"variation_number": "Variation 2", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless <del>exercise\",</del>  <ins>exercise,\"</ins> in which event the Company shall issue to the Holder the number of Warrant Shares <del>in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, as</del> determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the <del>Closing Sale Prices of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date</del>  <ins>last VWAP</ins> immediately preceding the <ins>time of delivery of the</ins> Exercise <del>Date;</del>  <ins>Notice giving rise to the applicable \"cashless exercise,\" as set forth in the applicable Exercise Notice (to clarify, the \"last VWAP\" will be the last VWAP as calculated over an entire Trading Day such that, in the event that this Warrant is exercised at a time that the Trading Market is open, the prior Trading Day's VWAP shall be used in this calculation);</ins> and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, <del>understood</del>  <ins>understood,</ins> and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). <del>In the event that a registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10.</del> Except as set forth in <del>Section 5(b) (Buy-In remedy) and</del> Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/quotient-ltd-4691/contract/244973/#clause-id-519340"}, {"variation_number": "Variation 3", "text": "Payment of Exercise Price. <del>Notwithstanding anything contained herein to</del>  <ins>If, and only if, at</ins> the <del>contrary,</del>  <ins>time of exercise hereof, there is no effective registration statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then</ins> the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless <del>exercise\",</del>  <ins>exercise,\"</ins> in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, <del>as</del> determined as follows: X = Y <del>[(A-B)/A] where:</del>  <ins>[(A-B)/A]where:</ins> \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale <del>Prices</del>  <ins>Price</ins> of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the <del>Commission</del>  <ins>SEC</ins> continues to take the position that such treatment is proper at the time of such exercise). <del>In the event that a registration statement registering the issuance of</del>  <ins>If</ins> Warrant Shares <del>is, for any reason, not effective</del>  <ins>are issued in such a cashless exercise, the Company acknowledges and agrees that, in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrants being exercised may be tacked on to the holding period of the Warrant Shares (provided that the SEC continues to take the position that such treatment is proper</ins> at the time of <del>exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10. Except as set forth in Section 5(b) (Buy-In remedy) and Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.</del>  <ins>such exercise).</ins>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/arsanis-inc-3909/contract/245337/#clause-id-520213"}, {"variation_number": "Variation 4", "text": "Payment of Exercise Price. <del>Notwithstanding anything</del>  <ins>This Warrant shall be exercised for cash; provided, however, that if at the time of exercise hereof there is no effective registration statement registering, or the prospectus</ins> contained <del>herein to</del>  <ins>therein is not available for,</ins> the <del>contrary,</del>  <ins>issuance of the Warrant Shares, and there is also no effective registration statement registering the resale by the Holder of the Warrant Shares, then</ins> the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless exercise\", in which event the Company shall issue to the Holder the number of <ins>the</ins> Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, as determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of <ins>the</ins> Warrant Shares to be issued to the Holder; \"Y\" equals the total number of <ins>the</ins> Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale <del>Prices</del>  <ins>Price per share</ins> of the <del>shares of</del> Common Stock <del>(as reported by Bloomberg Financial Markets)</del> as of the Trading Day <del>on the date</del> immediately preceding <ins>the Exercise Date if the Exercise Notice is delivered prior to market close on</ins> the Exercise Date; and \"B\" equals the Exercise Price <ins>per Warrant Share</ins> then in effect <del>for</del>  <ins>on</ins> the <del>applicable Warrant Shares at the time of such exercise.</del>  <ins>Exercise Date. 7</ins> For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). <del>In the event that a registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10.</del> Except as set forth in <del>Section 5(b) (Buy-In remedy) and</del> Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/neuroone-medical-technologies-corp-3895/contract/250302/#clause-id-528740"}, {"variation_number": "Variation 5", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless exercise\", in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, as determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale Prices of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. <del>For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). In the event that a registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10.</del> Except as set forth in Section 5(b) (Buy-In remedy) and Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/altimmune-inc-2816/contract/158017/#clause-id-321400"}, {"variation_number": "Variation 6", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless <del>exercise\",</del>  <ins>exercise,\"</ins> in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, <del>as</del> determined as follows: X = Y <del>[(A-B)/A] where:</del>  <ins>[(A-B)/A]where:</ins> \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale <del>Prices</del>  <ins>Price</ins> of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the <del>Commission</del>  <ins>SEC</ins> continues to take the position that such treatment is proper at the time of such exercise). In the event that a registration statement registering the issuance of <ins>the</ins> Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, <del>as</del>  <ins>245295022 v6 EX-4.1as</ins> set forth in this Section 10. <del>Except as set forth</del>  <ins>If Warrant Shares are issued</ins> in <ins>such a cashless exercise, the Company acknowledges and agrees that, in accordance with</ins> Section <del>5(b) (Buy-In remedy)</del>  <ins>3(a)(9) of the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised,</ins> and <del>Section 12 (payment</del>  <ins>the holding period</ins> of <del>cash in lieu</del>  <ins>the Warrants being exercised may be tacked on to the holding period</ins> of <del>fractional shares), in no event will</del> the <del>exercise</del>  <ins>Warrant Shares (provided that the SEC continues to take the position that such treatment is proper at the time</ins> of <del>this Warrant be settled in cash.</del>  <ins>such exercise).</ins>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/arsanis-inc-3909/contract/166321/#clause-id-339115"}, {"variation_number": "Variation 7", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless <del>exercise\",</del>  <ins>exercise,\"</ins> in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities <del>Act,</del>  <ins>Act</ins> as determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals <ins>(i)</ins> the <ins>last</ins> Closing Sale <del>Prices</del>  <ins>Price</ins> of the shares of Common Stock (as reported by <del>Bloomberg Financial Markets) as of</del>  <ins>Bloomberg) on</ins> the Trading Day <ins>immediately preceding the Exercise Date if the Exercise Notice is delivered prior to market close</ins> on the <del>date immediately preceding</del>  <ins>Exercise Date, or (ii) the last Closing Sale Price of the shares of Common Stock (as reported by Bloomberg) on the Exercise Date if the Exercise Notice is delivered following market close on</ins> the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, <ins>the Warrant Shares shall take on the registered characteristics of the Warrants being exercised,</ins> and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). In the event that <del>a</del>  <ins>the Registration Statement or another</ins> registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10. Except as set forth in Section 5(b) (Buy-In remedy) and Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash. <ins>For the avoidance of doubt, in the event that the Registration Statement or another registration statement registering the issuance of the Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then a cashless exercise pursuant to this Section 10 in exchange for unregistered Warrant Shares in accordance with Section 3(a)(9) of the Securities Act shall also be permitted.</ins>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/apellis-pharmaceuticals-inc-3820/contract/271051/#clause-id-570238"}, {"variation_number": "Variation 8", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless <del>exercise\",</del>  <ins>exercise,\"</ins> in which event the Company shall issue to the Holder the number of Warrant Shares <del>in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, as</del> determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the <ins>volume weighted average</ins> Closing Sale <del>Prices</del>  <ins>Price</ins> of the shares of Common Stock (as reported by Bloomberg Financial Markets) <del>as of</del>  <ins>over</ins> the <del>Trading Day</del>  <ins>seven (7) day-period ending</ins> on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). <del>In the event that a registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10.</del> Except as set forth in <del>Section 5(b) (Buy-In remedy) and</del> Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/corvus-pharmaceuticals-inc-5070/contract/82821/#clause-id-157635"}, {"variation_number": "Variation 9", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless <del>exercise\",</del>  <ins>exercise,\"</ins> in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, <del>as</del> determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale <del>Prices</del>  <ins>Price</ins> of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the <del>Commission</del>  <ins>SEC</ins> continues to take the position that such treatment is proper at the time of such exercise). In the event that a registration statement registering the issuance of <ins>the</ins> Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10. <del>Except as set forth</del>  <ins>If Warrant Shares are issued</ins> in <ins>such a cashless exercise, the Company acknowledges and agrees that, in accordance with</ins> Section <del>5(b) (Buy-In remedy)</del>  <ins>3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised,</ins> and <del>Section 12 (payment</del>  <ins>the holding period</ins> of <del>cash in lieu</del>  <ins>the Warrants being exercised may be tacked on to the holding period</ins> of <del>fractional shares), in no event will</del> the <del>exercise</del>  <ins>Warrant Shares (provided that the SEC continues to take the position that such treatment is proper at the time</ins> of <del>this Warrant be settled in cash.</del>  <ins>such exercise).</ins>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/syros-pharmaceuticals-inc-4295/contract/141410/#clause-id-277044"}, {"variation_number": "Variation 10", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless exercise\", in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, as determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale Prices of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). In the event that a registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10. Except as set forth in Section 5(b) (Buy-In remedy) and Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/aquinox-pharmaceuticals-inc-3280/contract/80646/#clause-id-152713"}, {"variation_number": "Variation 11", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless <del>exercise\",</del>  <ins>exercise,\"</ins> in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, <del>as</del> determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale <del>Prices</del>  <ins>Price</ins> of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the <del>Commission</del>  <ins>SEC</ins> continues to take the position that such treatment is proper at the time of such exercise). In the event that <del>a</del>  <ins>the Registration Statement, or another</ins> registration statement registering the issuance of <ins>the</ins> Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10. <del>Except</del>  <ins>If Warrant Shares are issued in such a cashless exercise, the Company acknowledges and agrees that in accordance with Section 3(a)(9) of the Securities Act of 1933,</ins> as <del>set forth in Section 5(b) (Buy-In remedy)</del>  <ins>amended, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised,</ins> and <del>Section 12 (payment</del>  <ins>the holding period</ins> of <del>cash in lieu</del>  <ins>the Warrants being exercised may be tacked on to the holding period</ins> of <del>fractional shares), in no event will</del> the <del>exercise of this</del> Warrant <del>be settled in cash.</del>  <ins>Shares.</ins>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/savara-inc-2325/contract/163793/#clause-id-332950"}, {"variation_number": "Variation 12", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless <del>exercise\",</del>  <ins>exercise,\"</ins> in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, <del>as</del> determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale <del>Prices</del>  <ins>Price</ins> of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the <del>Commission</del>  <ins>SEC</ins> continues to take the position that such treatment is proper at the time of such exercise). In the event that a registration statement registering the issuance of <ins>the</ins> Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10. <del>Except</del>  <ins>If Warrant Shares are issued in such a cashless exercise, the Company acknowledges and agrees that in accordance with Section 3(a)(9) of the Securities Act of 1933,</ins> as <del>set forth in Section 5(b) (Buy-In remedy)</del>  <ins>amended, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised,</ins> and <del>Section 12 (payment</del>  <ins>the holding period</ins> of <del>cash in lieu</del>  <ins>the Warrants being exercised may be tacked on to the holding period</ins> of <del>fractional shares), in no event will</del> the <del>exercise of this</del> Warrant <del>be settled in cash.</del>  <ins>Shares.</ins>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/savara-inc-2325/contract/79496/#clause-id-150278"}, {"variation_number": "Variation 13", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless exercise\", in which event the Company shall issue to the Holder the number of Warrant Shares <del>in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, as</del> determined as follows: X = Y [(A-B)/A] where: <ins>-5-</ins> \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the <ins>average of the</ins> Closing Sale Prices of the shares of Common Stock (as reported by Bloomberg Financial Markets) <del>as of</del>  <ins>for</ins> the <ins>five (5) consecutive</ins> Trading <del>Day</del>  <ins>Days ending</ins> on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). In the event that <del>a registration statement registering</del> the <del>issuance of Warrant Shares</del>  <ins>Registration Statement</ins> is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10. <del>Except as set forth in Section 5(b) (Buy-In remedy) and Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.</del>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/savara-inc-2325/contract/496457/#clause-id-1116518"}, {"variation_number": "Variation 14", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless <del>exercise\",</del>  <ins>exercise,\"</ins> in which event the Company shall issue to the Holder the number of Warrant Shares <del>in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, as</del> determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; <ins>5</ins> \"Y\" equals the totalnumber of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the <ins>average of the</ins> Closing Sale Prices of the shares of Common Stock (as reported by Bloomberg Financial Markets) <del>as of</del>  <ins>for</ins> the <ins>five (5) consecutive</ins> Trading <del>Day</del>  <ins>Days ending</ins> on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). <del>In the event that a registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10.</del> Except as set forth in Section 5(b) (Buy-In remedy) and Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/syndax-pharmaceuticals-inc-3218/contract/49541/#clause-id-82906"}, {"variation_number": "Variation 15", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless <del>exercise\",</del>  <ins>exercise,\"</ins> in which event the Company shall issue to the Holder the number of Warrant Shares <del>in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, as</del> determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the <ins>average of the</ins> Closing Sale Prices of the shares of Common Stock (as reported by Bloomberg Financial Markets) <del>as of</del>  <ins>for</ins> the <ins>five (5) consecutive</ins> Trading <del>Day</del>  <ins>Days ending</ins> on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). <del>In the event that a registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10.</del> Except as set forth in <del>Section 5(b) (Buy-In remedy) and</del> Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/protagonist-therapeutics-inc-3096/contract/278650/#clause-id-583931"}]}
{"clause_number": "Clause 3", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. (a) Payment Options. The exercise price shall be paid by one or any combination of the following forms of payment that are applicable to this option, as indicated on the cover page hereof: (i) by check payable to the order of the Company; or (ii) delivery of an irrevocable and unconditional undertaking, satisfactory in form and substance to the Company, by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price, or delivery by the Optionee to the Company of a copy of irrevocable and unconditional instructions, satisfactory in form and substance to the Company, to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price; or (iii) subject to Section 7(b) below, if the Common Stock is then traded on a national securities exchange or on the Nasdaq National Market (or successor trading system), by delivery of shares of Common Stock having a fair market value equal as of the date of exercise to the option price. In the case of (iii) above, fair market value as of the date of exercise shall be determined as of the last business day for which such prices or quotes are available prior to the date of exercise and shall mean (i) the last reported sale price (on that date) of the Common Stock on the principal national securities exchange on which the Common Stock is traded, if the Common Stock is then traded on a national securities exchange; or (ii) the last reported sale price (on that date) of the Common Stock on the Nasdaq National Market (or successor trading system), if the Common Stock is not then traded on a national securities exchange. (b) Limitations on Payment by Delivery of Common Stock. If Section 7(a)(iii) is applicable, and if the Optionee delivers Common Stock held by the Optionee (\"Old Stock\") to the Company in full or partial payment of the exercise price and the Old Stock so delivered is subject to restrictions or limitations imposed by agreement between the Optionee and the Company, an equivalent number of Shares shall be subject to all restrictions and limitations applicable to the Old Stock to the extent that the Optionee paid for the Shares by delivery of Old Stock, in addition to any restrictions or limitations imposed by this agreement. Notwithstanding the foregoing, the Optionee may not pay any part of the exercise price hereof by transferring Common Stock to the Company unless such Common Stock has been owned by the Optionee free of any substantial risk of forfeiture for at least six months.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/imprivata-inc-19874/contract/406636/#clause-id-870698", "variations": [{"variation_number": "Variation 1", "text": "Payment of Exercise Price. (a) Payment Options. The exercise price shall be paid by one or any combination of the following forms of payment that are applicable to this option, as indicated on the cover page hereof: (i) by check payable to the order of the Company; or (ii) delivery of an irrevocable and unconditional undertaking, satisfactory in form and substance to the Company, by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price, or delivery by the Optionee to the Company of a copy of irrevocable and unconditional instructions, satisfactory in form and substance to the Company, to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price; or (iii) subject to Section 7(b) below, if the Common Stock is then traded on a national securities exchange or on the Nasdaq National Market (or successor trading system), by delivery of shares of Common Stock having a fair market value equal as of the date of exercise to the option price. In the case of (iii) above, fair market value as of the date of exercise shall be determined as of the last business day for which such prices or quotes are available prior to the date of exercise and shall mean (i) the last reported sale price (on that date) of the Common Stock on the principal national securities exchange on which the Common Stock is traded, if the Common Stock is then traded on a national securities exchange; or (ii) the last reported sale price (on that date) of the Common Stock on the Nasdaq National Market (or successor trading system), if the Common Stock is not then traded on a national securities exchange. (b) Limitations on Payment by Delivery of Common Stock. If Section 7(a)(iii) is applicable, and if the Optionee delivers Common Stock held by the Optionee (\"Old Stock\") to the Company in full or partial payment of the exercise price and the Old Stock so delivered is subject to restrictions or limitations imposed by agreement between the Optionee and the Company, an equivalent number of Shares shall be subject to all restrictions and limitations applicable to the Old Stock to the extent that the Optionee paid for the Shares by delivery of Old Stock, in addition to any restrictions or limitations imposed by this agreement. Notwithstanding the foregoing, the Optionee may not pay any part of the exercise price hereof by transferring Common Stock to the Company unless such Common Stock has been owned by the Optionee free of any substantial risk of forfeiture for at least six months.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/imprivata-inc-19874/contract/406636/#clause-id-870698"}, {"variation_number": "Variation 2", "text": "Payment of Exercise Price. (a) Payment Options. The exercise price <del>shall</del>  <ins>and any required withholding taxes may</ins> be paid by one or any combination of the following forms of payment that are applicable to this option, as indicated on the cover page hereof: (i) by check payable to the order of the Company; <del>or</del> (ii) <ins>if the Common Stock is then publicly traded,</ins> delivery of an irrevocable and unconditional undertaking, satisfactory in form and substance to the Company, by a creditworthy broker to deliver promptly to the Companysufficient funds to pay the exercise <del>price,</del>  <ins>price and any required tax withholding;</ins> or delivery by the Optionee to the Company of a copy of irrevocable and unconditional instructions, satisfactory in form and substance to the Company, to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise <del>price; or</del>  <ins>price and any required tax withholding; 5</ins> (iii) subject to Section <del>7(b)</del>  <ins>8(b)</ins> below, if the Common Stock is then traded on a national securities exchange or <del>on the Nasdaq National Market (or successor</del>  <ins>another national</ins> trading <del>system),</del>  <ins>system,</ins> by delivery of shares of Common Stock having a fair market value equal as of the date of exercise to the <del>option price.</del>  <ins>exercise price and any required tax withholding; (iv) at the discretion of the Company's Board of Directors and in compliance with the Sarbanes-Oxley Act of 2002, as amended, by delivery of the Optionee's personal recourse note bearing interest payable not less than annually at no less than 100% of the applicable Federal rate, as defined in Section 1274(d) of the Code; or (v) by any combination of the foregoing equal in amount to the Exercise Price.</ins> In the case of (iii) above, fair market value as of the date of exercise shall be determined as of the last business day for which such prices or quotes are available prior to the date of exercise and shall mean (i) the last reported sale price (on that date) of the Common Stock on the principal national securities exchange on which the Common Stock is traded, if the Common Stock is then traded on a national securities exchange; or (ii) the last reported sale price (on that date) of the Common Stock on <del>the Nasdaq National Market (or successor</del>  <ins>another national</ins> trading <del>system),</del>  <ins>system,</ins> if the Common Stock is not then traded on a national securities exchange. (b) Limitations on Payment by Delivery of Common Stock. If Section <del>7(a)(iii)</del>  <ins>8(a)(iii)</ins> is applicable, and if the Optionee delivers Common Stock held by the Optionee (\"Old Stock\") to the Company in full or partial payment of the exercise price and <ins>required tax withholding and</ins> the Old Stock so delivered is subject to restrictions or limitations imposed by agreement between the Optionee and the Company, <del>an equivalent</del>  <ins>a</ins> number of Shares shall be subject to all restrictions and limitations applicable to the Old Stock to the extent that the Optionee paid for the Shares by delivery of Old Stock, in addition to any restrictions or limitations imposed by this <del>agreement. Notwithstanding the foregoing, the Optionee may not pay any part of the exercise price hereof by transferring Common Stock to the Company unless such Common Stock has been owned by the Optionee free of any substantial risk of forfeiture for at least six months.</del>  <ins>Agreement.</ins>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/cyteir-therapeutics-inc-13084/contract/181002/#clause-id-373263"}, {"variation_number": "Variation 3", "text": "Payment of Exercise Price. (a) Payment Options. The exercise price <del>shall</del>  <ins>and any required withholding taxes may</ins> be paid by one or any combination of the following forms of payment that are applicable to this option, as indicated on the cover page hereof: (i) by <ins>cash or a certified or bank</ins> check payable to the order of the Company; or (ii) <ins>if the Common Stock is then publicly traded,</ins> delivery of an irrevocable and unconditional undertaking, satisfactory in form and substance to the Company, by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price, <ins>and any required tax withholding;</ins> or delivery by the Optionee to the Company of a copy of irrevocable and unconditional instructions, satisfactory in form and substance to the Company, to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise <del>price;</del>  <ins>price and any required tax withholding;</ins> or (iii) subject to Section <del>7(b)</del>  <ins>6(b)</ins> below, <del>if the Common Stock is then traded on a national securities exchange or on the Nasdaq National Market (or successor trading system),</del> by delivery of shares of Common Stock <ins>of the Company</ins> having a <del>fair market value</del>  <ins>Fair Market Value</ins> equal as of the date of exercise to the <del>option price.</del>  <ins>exercise price and any required tax withholding.</ins> In the case of (iii) above, <del>fair market value</del>  <ins>\"Fair Market Value\"</ins> as of the date of exercise shall be determined as of the last business day for which such prices or quotes are available prior to the date of exercise and shall mean (i) the <del>last reported sale</del>  <ins>closing</ins> price (on that date) of the Common Stock on the principal national securities exchange on which the Common Stock is traded, if the Common Stock is then traded on a national securities exchange; or (ii) the last reported sale price (on that date) of the Common Stock on the <del>Nasdaq National</del>  <ins>NASDAQ Global Select Market, the NSADAQ Global</ins> Market <del>(or successor trading system),</del>  <ins>or the NASDAQ Capital Market (collectively \"Nasdaq\"),</ins> if the Common Stock is not then traded on a national securities <del>exchange.</del>  <ins>exchange; or (iii) the average of the closing bid and asked prices last quoted (on that date) by an established quotation service for over-the-counter securities, if the Common Stock is not then traded on a national securities exchange or reported on Nasdaq. 4</ins> (b) Limitations on Payment by Delivery of Common Stock. If Section <del>7(a)(iii)</del>  <ins>6(a)(iii)</ins> is applicable, and if the Optionee delivers Common Stock held by the Optionee (\"Old Stock\") to the Company in full or partial payment of the exercise price and <ins>required tax withholding and</ins> the Old Stock so delivered is subject to restrictions or limitations imposed by agreement between the Optionee and the Company, <del>an equivalent</del>  <ins>a</ins> number of Shares shall be subject to all restrictions and limitations applicable to the Old Stock to the extent that the Optionee paid for the Shares by delivery of Old Stock, in addition to any restrictions or limitations imposed by this <del>agreement.</del>  <ins>Agreement.</ins> Notwithstanding the foregoing, the Optionee may not pay any part of the exercise price hereof <ins>or required tax withholding</ins> by transferring Common Stock to the Company unless such Common Stock has been owned by the Optionee free of any substantial risk of forfeiture for at least six months. <ins>If the Optionee exercises this option by delivery of shares of Common Stock of the Company, the certificate or certificates representing the shares of Common Stock of the Company to be delivered shall be duly executed in blank suitable for purposes of transferring such shares to the Company.</ins>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/world-surveillance-group-inc-28230/contract/450592/#clause-id-998654"}, {"variation_number": "Variation 4", "text": "Payment of Exercise Price. (a) Payment Options. The exercise price <del>shall</del>  <ins>and any required withholding taxes may</ins> be paid by one or any combination of the following forms of payment that are applicable to this option, as indicated on the cover page hereof: (i) by <ins>cash or a certified or bank</ins> check payable to the order of the Company; or (ii) <ins>if the Common Stock is then publicly traded,</ins> delivery of an irrevocable and unconditional undertaking, satisfactory in form and substance to the Company, by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price, <ins>and any required tax withholding;</ins> or delivery by the Optionee to the Company of a copy of irrevocable and unconditional instructions, satisfactory in form and substance to the Company, to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise <del>price;</del>  <ins>price and any required tax withholding;</ins> or (iii) subject to Section <del>7(b)</del>  <ins>6(b)</ins> below, <del>if the Common Stock is then traded on a national securities exchange or on the Nasdaq National Market (or successor trading system),</del> by delivery of shares of Common Stock <ins>of the Company</ins> having a <del>fair market value</del>  <ins>Fair Market Value</ins> equal as of the date of exercise to the <del>option price.</del>  <ins>exercise price and any required tax withholding.</ins> In the case of (iii) above, <del>fair market value</del>  <ins>\"Fair Market Value\"</ins> as of the date of exercise shall be determined as of the last business day for which such prices or quotes are available prior to the date of exercise and shall mean (i) the <del>last reported sale</del>  <ins>closing</ins> price (on that date) of the Common Stock on the principal national securities exchange on which the Common Stock is traded, if the Common Stock is then traded on a national securities exchange; or (ii) the last reported sale price (on that date) of the Common Stock on the <del>Nasdaq National</del>  <ins>NASDAQ Global Select Market, the NSADAQ Global</ins> Market <del>(or successor trading system),</del>  <ins>or the NASDAQ Capital Market (collectively \"Nasdaq\"),</ins> if the Common Stock is not then traded on a national securities <del>exchange.</del>  <ins>exchange; or (iii) the average of the closing bid and asked prices last quoted (on that date) by an established quotation service for over-the-counter securities, if the Common Stock is not then traded on a national securities exchange or reported on Nasdaq.</ins> (b) Limitations on Payment by Delivery of Common Stock. If Section <del>7(a)(iii)</del>  <ins>6(a)(iii)</ins> is applicable, and if the Optionee delivers Common Stock held by the Optionee (\"Old Stock\") to the Company in full or partial payment of the exercise price and <ins>required tax withholding and</ins> the Old Stock so delivered is subject to restrictions or limitations imposed by agreement between the Optionee and the Company, <del>an equivalent</del>  <ins>a</ins> number of Shares shall be subject to all restrictions and limitations applicable to the Old Stock to the extent that the Optionee paid for the Shares by delivery of Old Stock, in addition to any restrictions or limitations imposed by this <del>agreement.</del>  <ins>Agreement.</ins> Notwithstanding the foregoing, the Optionee may not pay any part of the exercise price hereof <ins>or required tax withholding</ins> by transferring Common Stock to the Company unless such Common Stock has been owned by the Optionee free of any substantial risk of forfeiture for at least six months. <ins>If the Optionee exercises this option by delivery of shares of Common Stock of the Company, the certificate or certificates representing the shares of Common Stock of the Company to be delivered shall be duly executed in blank suitable for purposes of transferring such shares to the Company.</ins>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/world-surveillance-group-inc-28230/contract/450594/#clause-id-998664"}, {"variation_number": "Variation 5", "text": "Payment of Exercise Price. (a) Payment Options. The exercise price <del>shall</del>  <ins>and any required withholding taxes may</ins> be paid by one or any combination of the following forms of payment that are applicable to this option, as indicated on the cover page hereof: (i) by check payable to the order of the Company; <del>or</del> (ii) <ins>if the Common Stock is then publicly traded,</ins> delivery of an irrevocable and unconditional undertaking, satisfactory in form and substance to the Company, by a creditworthy broker to deliver promptly to the Companysufficient funds to pay the exercise <del>price,</del>  <ins>price and any required tax withholding;</ins> or delivery by the Optionee to the Company of a copy of irrevocable and unconditional instructions, satisfactory in form and substance to the Company, to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise <del>price;</del>  <ins>price and any required tax withholding;</ins> or <ins>5</ins> (iii) subject to Section <del>7(b)</del>  <ins>8(b)</ins> below, if the Common Stock is then traded on a national securities exchange or <del>on the Nasdaq National Market (or successor</del>  <ins>another national</ins> trading <del>system),</del>  <ins>system,</ins> by delivery of shares of Common Stock having a fair market value equal as of the date of exercise to the <del>option price.</del>  <ins>exercise price and any required tax withholding.</ins> In the case of (iii) above, fair market value as of the date of exercise shall be determined as of the last business day for which such prices or quotes are available prior to the date of exercise and shall mean (i) the last reported sale price (on that date) of the Common Stock on the principal national securities exchange on which the Common Stock is traded, if the Common Stock is then traded on a national securities exchange; or (ii) the last reported sale price (on that date) of the Common Stock on <del>the Nasdaq National Market (or successor</del>  <ins>another national</ins> trading <del>system),</del>  <ins>system,</ins> if the Common Stock is not then traded on a national securities exchange. (b) Limitations on Payment by Delivery of Common Stock. If Section <del>7(a)(iii)</del>  <ins>8(a)(iii)</ins> is applicable, and if the Optionee delivers Common Stock held by the Optionee (\"Old Stock\") to the Company in full or partial payment of the exercise price and <ins>required tax withholding and</ins> the Old Stock so delivered is subject to restrictions or limitations imposed by agreement between the Optionee and the Company, <del>an equivalent</del>  <ins>a</ins> number of Shares shall be subject to all restrictions and limitations applicable to the Old Stock to the extent that the Optionee paid for the Shares by delivery of Old Stock, in addition to any restrictions or limitations imposed by this <del>agreement. Notwithstanding the foregoing, the Optionee may not pay any part of the exercise price hereof by transferring Common Stock to the Company unless such Common Stock has been owned by the Optionee free of any substantial risk of forfeiture for at least six months.</del>  <ins>Agreement.</ins>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/cyteir-therapeutics-inc-13084/contract/181001/#clause-id-373252"}, {"variation_number": "Variation 6", "text": "Payment of Exercise Price. (a) Payment Options. The exercise price shall be paid by one or any combination of the following forms of payment that are applicable to this <del>option,</del>  <ins>award,</ins> as indicated on the cover page hereof: (i) by check payable to the order of the Company; or (ii) delivery of an irrevocable and unconditional undertaking, satisfactory in form and substance to the Company, by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price, or delivery by the <del>Optionee</del>  <ins>Parti cipant</ins> to the Company of a copy of irrevocable and unconditional instructions, satisfactory in form and substance to the Company, to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price; or (iii) subject to Section 7(b) below, if the Common Stock is then traded on a national securities exchange or on the Nasdaq National Market (or successor trading system), by delivery of shares of Common Stock having a fair market value equal as of the date of exercise to the <del>option</del>  <ins>award</ins> price. In the case of (iii) above, fair market value as of the date of exercise shall be determined as of the last business day for which such prices or quotes are available prior to the date of exercise and shall mean (i) the last reported sale price (on that date) of the Common Stock on the principal national securities exchange on which the Common Stock is traded, if the Common Stock is then traded on a national securities exchange; or (ii) the last reported sale price (on that date) of the Common Stock on the Nasdaq National Market (or successor trading system), if the Common Stock is not then traded on a national securities exchange. (b) Limitations on Payment by Delivery of Common Stock. If Section 7(a)(iii) is applicable, and if the <del>Optionee</del>  <ins>Participant</ins> delivers Common Stock held by the <del>Optionee</del>  <ins>Participant</ins> (\"Old Stock\") to the Company in full or partial payment of the exercise price and the Old Stock so delivered is subject to restrictions or limitations imposed by agreement between the <del>Optionee</del>  <ins>Participant</ins> and the Company, an equivalent number of <ins>Award</ins> Shares shall be subject to all restrictions and limitations applicable to the Old Stock to the extent that the <del>Optionee</del>  <ins>Participant</ins> paid for the <ins>Award</ins> Shares by delivery of Old Stock, in addition to any restrictions or limitations imposed by this <del>agreement.</del>  <ins>Agreement.</ins> Notwithstanding the foregoing, the <del>Optionee</del>  <ins>Participant</ins> may not pay any part of the exercise price hereof by transferring Common Stock to the Company unless such Common Stock has been owned by the <del>Optionee</del>  <ins>Participant</ins> free of any substantial risk of forfeiture for at least six months.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/acell-inc-10314/contract/106340/#clause-id-196652"}, {"variation_number": "Variation 7", "text": "Payment of Exercise Price. (a) Payment Options. The exercise price shall be paid by one or any combination of the following forms of payment that are applicable to this option, as indicated on the cover page hereof: (i) by check payable to the order of the Company; or (ii) <ins>if the Common Stock is then traded on a national securities exchange or the OTC (or successor trading system),</ins> delivery of an irrevocable and unconditional undertaking, satisfactory in form and substance to the Company, by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price, or delivery by the <del>Optionee</del>  <ins>Participant</ins> to the Company of a copy of irrevocable and unconditional instructions, satisfactory in form and substance to the Company, to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price; or (iii) subject to Section 7(b) below, if the Common Stock is then traded on a national securities exchange or <del>on</del> the <del>Nasdaq National Market</del>  <ins>OTC</ins> (or successor trading system), by delivery of shares of Common Stock having a fair market value equal as of the date of exercise to the option price. In the case of (iii) above, fair market value as of the date of exercise shall be determined as of the last business day for which such prices or quotes are available prior to the date of exercise and shall mean (i) the last reported sale price (on that date) of the Common Stock on the principal national securities exchange on which the Common Stock is traded, if the Common Stock is then traded on a national securities exchange; or (ii) the last reported sale price (on that date) of the Common Stock on the <del>Nasdaq National Market</del>  <ins>OTC</ins> (or successor trading system), if the Common Stock is not then traded on a national securities exchange. (b) Limitations on Payment by Delivery of Common Stock. If Section 7(a)(iii) is applicable, and if the <del>Optionee</del>  <ins>Participant</ins> delivers Common Stock held by the <del>Optionee</del>  <ins>Participant</ins> (\"Old Stock\") to the Company in full or partial payment of the exercise price and the Old Stock so delivered is subject to restrictions or limitations imposed by agreement between the <del>Optionee</del>  <ins>Participant</ins> and the Company, an equivalent number of <ins>Option</ins> Shares shall be subject to all restrictions and limitations applicable to the Old Stock to the extent that the <del>Optionee</del>  <ins>Participant</ins> paid for the <ins>Option</ins> Shares by delivery of Old Stock, in addition to any restrictions or limitations imposed by this <del>agreement.</del>  <ins>Agreement.</ins> Notwithstanding the foregoing, the <del>Optionee</del>  <ins>Participant</ins> may not pay any part of the exercise price hereof by transferring Common Stock to the Company unless such Common Stock has been owned by the <del>Optionee</del>  <ins>Participant</ins> free of any substantial risk of forfeiture for at least six months.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/protagonist-therapeutics-inc-3096/contract/346233/#clause-id-750609"}]}
{"clause_number": "Clause 4", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. When you submit your notice of exercise, you must include payment of the exercise price of the Shares being purchased through one or a combination of the following methods: (a) Cash (including personal check, cashier's check or money order); (b) By means of a broker-assisted cashless exercise in which you irrevocably instruct your broker to deliver proceeds of a sale of all or a portion of the Shares to be issued pursuant to the exercise to the Company in payment of the exercise price of such Shares; or (c) By delivery to the Company of Shares (by actual delivery or attestation of ownership in a form approved by the Company) already owned by you that are not subject to any security interest and that have an aggregate Fair Market Value on the date of exercise equal to the exercise price of the Shares being purchased; or (d) By authorizing the Company to retain, from the total number of Shares as to which the Option is being exercised, that number of Shares having a Fair Market Value on the date of exercise equal to the exercise price for the total number of Shares as to which the Option is being exercised. However, if the Committee determines, in any given circumstance, that payment of the exercise price with Shares or by authorizing the Company to retain Shares is undesirable for any reason, you will not be permitted to pay any portion of the exercise price in that manner.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/mobivity-holdings-corp-3577/contract/356483/#clause-id-776773", "variations": [{"variation_number": "Variation 1", "text": "Payment of Exercise Price. When you submit your notice of exercise, you must include payment of the exercise price of the Shares being purchased through one or a combination of the following methods: (a) Cash (including personal check, cashier's check or money order); (b) By means of a broker-assisted cashless exercise in which you irrevocably instruct your broker to deliver proceeds of a sale of all or a portion of the Shares to be issued pursuant to the exercise to the Company in payment of the exercise price of such Shares; or (c) By delivery to the Company of Shares (by actual delivery or attestation of ownership in a form approved by the Company) already owned by you that are not subject to any security interest and that have an aggregate Fair Market Value on the date of exercise equal to the exercise price of the Shares being purchased; or (d) By authorizing the Company to retain, from the total number of Shares as to which the Option is being exercised, that number of Shares having a Fair Market Value on the date of exercise equal to the exercise price for the total number of Shares as to which the Option is being exercised. However, if the Committee determines, in any given circumstance, that payment of the exercise price with Shares or by authorizing the Company to retain Shares is undesirable for any reason, you will not be permitted to pay any portion of the exercise price in that manner.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/mobivity-holdings-corp-3577/contract/356483/#clause-id-776773"}, {"variation_number": "Variation 2", "text": "Payment of Exercise Price. When you submit your notice of exercise, you must include payment of the exercise price of the Shares being purchased through one or a combination of the following methods: (a) Cash <del>(including personal check, cashier's check</del> or <del>money order);</del>  <ins>by promissory note;</ins> (b) By means of a broker-assisted cashless exercise in which you irrevocably instruct your broker to deliver proceeds of a sale of all or a portion of the Shares to be issued pursuant to the exercise to the Company in payment of the exercise price of such Shares; or (c) By delivery to the Company of Shares (by actual delivery or attestation of ownership in a form approved by the Company) already owned by you that are not subject to any security interest and that have an aggregate Fair Market Value on the date of exercise equal to the exercise price of the Shares being <del>purchased; or (d) By authorizing the Company to retain, from the total number of Shares as to which the Option is being exercised, that number of Shares having a Fair Market Value on the date of exercise equal to the exercise price for the total number of Shares as to which the Option is being exercised. However, if the Committee determines, in any given circumstance, that payment of the exercise price with Shares or by authorizing the Company to retain Shares is undesirable for any reason, you will not be permitted to pay any portion of the exercise price in that manner.</del>  <ins>purchased.</ins>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/audioeye-inc-3006/contract/141928/#clause-id-278584"}, {"variation_number": "Variation 3", "text": "Payment of Exercise Price. When you submit your notice of exercise, you must include payment of the exercise price of the Shares being purchased through one or a combination of the following methods: (a) Cash (including personal check, cashier's check or money order); (b) By means of a broker-assisted cashless exercise in which you irrevocably instruct your broker to deliver proceeds of a sale of all or a portion of the Shares to be issued pursuant to the exercise to the Company in payment of the exercise price of such Shares; or (c) By delivery to the Company of Shares (by actual delivery or attestation of ownership in a form approved by the Company) already owned by you that are not subject to any security interest and that have an aggregate Fair Market Value on the date of exercise equal to the exercise price of the Shares being <del>purchased; or (d) By authorizing the Company to retain, from the total number of Shares as to which the Option is being exercised, that number of Shares having a Fair Market Value on the date of exercise equal to the exercise price for the total number of Shares as to which the Option is being exercised.</del>  <ins>purchased.</ins> However, if the Committee determines, in any given circumstance, that payment of the exercise price with <del>Shares or by authorizing the Company to retain</del> Shares is undesirable for any reason, you will not be permitted to pay any portion of the exercise price in that manner.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/colucid-pharmaceuticals-inc-18528/contract/457896/#clause-id-1018063"}, {"variation_number": "Variation 4", "text": "Payment of Exercise Price. When you submit your notice of exercise, you must include payment of the exercise price of the Shares being purchased through one or a combination of the following methods: (a) Cash <del>(including personal check, cashier's check</del> or <del>money order);</del>  <ins>by promissory note;</ins> (b) By means of a broker-assisted cashless exercise in which you irrevocably instruct your broker to deliver proceeds of a sale of all or a portion of the Shares to be issued pursuant to the exercise to the Company in payment of the exercise price of such Shares; <del>or</del> (c) By delivery to the Company of Shares (by actual delivery or attestation of ownership in a form approved by the Company) already owned by you that are not subject to any security interest and that have an aggregate Fair Market Value on the date of exercise equal to the exercise price of the Shares being purchased; or (d) By authorizing the Company to retain, from the total number of Shares as to which the Option is being exercised, that number of Shares having a Fair Market Value on the date of exercise equal to the exercise price for the total number of Shares as to which the Option is being exercised. <del>However, if the Committee determines, in any given circumstance, that payment of the exercise price with Shares or by authorizing the Company to retain Shares is undesirable for any reason, you will not be permitted to pay any portion of the exercise price in that manner.</del>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/audioeye-inc-3006/contract/141929/#clause-id-278592"}, {"variation_number": "Variation 5", "text": "Payment of Exercise Price. When you submit your notice of exercise, you must include payment of the exercise price of the Shares being purchased through one or a combination of the following methods: <ins>2</ins> (a) Cash (including personal check, cashier's check or money order); (b) By means of a broker-assisted cashless exercise in which you irrevocably instruct your broker to deliver proceeds of a sale of all or a portion of the Shares to be issued pursuant to the exercise to the Company in payment of the exercise price of suchShares; or (c) By delivery to the Company of Shares (by actual delivery or attestation of ownership in a form approved by the Company) already owned by you that are not subject to any security interest and that have an aggregate Fair Market Value on the date of exercise equal to the exercise price of the Shares being purchased; or (d) By authorizing the Company to retain, from the total number of Shares as to which the Option is being exercised, that number of Shares having a Fair Market Value on the date of exercise equal to the exercise price for the total number of Shares as to which the Option is being exercised. <del>However, if the Committee determines, in any given circumstance, that payment of the exercise price with Shares or by authorizing the Company to retain Shares is undesirable for any reason, you will not be permitted to pay any portion of the exercise price in that manner.</del>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/insignia-systems-inc-7485/contract/294582/#clause-id-624621"}]}
{"clause_number": "Clause 5", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. Payment of the Exercise Price due upon the exercise of the Stock Options may be made in any one or in any combination of the following forms: (a) in cash (by a certified or cashier's check); (b) in the form of shares of Common Stock owned by the Consultant having a Fair Market Value equal to the total Exercise Price at the time of the exercise, accompanied by and duly endorsed or accompanied by stock transfer powers, (c) in the form of shares of restricted stock issued to the Consultant havinga Fair Market Value equal to the total Exercise Price at the time of the exercise, accompanied by and duly endorsed or accompanied by stock transfer powers; (d) through simultaneous sale through a broker acceptable to the Committee of shares of Common Stock issuable to the Consultant on exercise, as permitted under Regulation T of the Board of Governors of the Federal Reserve System.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/marker-therapeutics-inc-2050/contract/480175/#clause-id-1074483", "variations": [{"variation_number": "Variation 1", "text": "Payment of Exercise Price. Payment of the Exercise Price due upon the exercise of the Stock Options may be made in any one or in any combination of the following forms: (a) in cash (by a certified or cashier's check); (b) in the form of shares of Common Stock owned by the Consultant having a Fair Market Value equal to the total Exercise Price at the time of the exercise, accompanied by and duly endorsed or accompanied by stock transfer powers, (c) in the form of shares of restricted stock issued to the Consultant havinga Fair Market Value equal to the total Exercise Price at the time of the exercise, accompanied by and duly endorsed or accompanied by stock transfer powers; (d) through simultaneous sale through a broker acceptable to the Committee of shares of Common Stock issuable to the Consultant on exercise, as permitted under Regulation T of the Board of Governors of the Federal Reserve System.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/marker-therapeutics-inc-2050/contract/480175/#clause-id-1074483"}, {"variation_number": "Variation 2", "text": "Payment of Exercise Price. Payment of the Exercise Price due upon the exercise of the Stock Options may be made in any one or in any combination of the following forms: (a) in cash (by a certified or cashier's check); (b) in the form of shares of Common Stock owned by the <del>Consultant</del>  <ins>Director</ins> having a Fair Market Value equal to the total Exercise Price at the time of the exercise, accompanied by and duly endorsed or accompanied by stock transfer <del>powers,</del>  <ins>powers;</ins> (c) in the form of shares of restricted stock issued to the<ins>Director</ins> having a Fair Market Value equal to the total Exercise Price at the time of the exercise, accompanied by and duly endorsed or accompanied by stock transfer powers; (d) through simultaneous sale through a broker acceptable to the Committee of shares of Common Stock issuable to the <del>Consultant</del>  <ins>Director</ins> on exercise, as permitted under Regulation T of the Board of Governors of the Federal Reserve System.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/marker-therapeutics-inc-2050/contract/480173/#clause-id-1074474"}, {"variation_number": "Variation 3", "text": "Payment of Exercise Price. Payment of the Exercise Price due upon the exercise of the Stock Options may be made in any one or in any combination of the following forms: (a) in cash (by a certified or cashier's check); (b) in the form of shares of Common Stock owned by the <del>Consultant</del>  <ins>Participant</ins> having a Fair Market Value equal to the total Exercise Price at the time of the exercise, accompanied by and duly endorsed or accompanied by stock transfer <del>powers,</del>  <ins>powers;</ins> (c) in the form of shares of restricted stock issued tothe <del>Consultant</del>  <ins>Participant</ins> having a Fair Market Value equal to the total Exercise Price at the time of the exercise, accompanied by and duly endorsed or accompanied by stock transfer powers; (d) through simultaneous sale through a broker acceptable to the Committee of shares of Common Stock issuable to the <del>Consultant</del>  <ins>Participant</ins> on exercise, as permitted under Regulation T of the Board of Governors of the Federal Reserve System.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/marker-therapeutics-inc-2050/contract/480171/#clause-id-1074464"}, {"variation_number": "Variation 4", "text": "Payment of Exercise Price. Payment of the Exercise Price due upon the exercise of the Stock Options may be made in any one or in any combination of the following forms: <del>(a) in</del>  <ins>(a)in</ins> cash (by a certified or cashier's check); <del>(b) in</del>  <ins>(b)in</ins> the form of shares of Common Stock owned by the Consultant having a Fair Market Value equal to the total Exercise Price at the time of the exercise, accompanied by and duly endorsed or accompanied by stock transfer powers, <del>(c) in</del>  <ins>(c)in</ins> the form of shares of <del>restricted</del> stock issued to theConsultant <ins>(or issuable to the Consultant pursuant to the exercise of the Stock Options)</ins> having a Fair Market Value equal to the total Exercise Price at the time of the exercise, accompanied by and duly endorsed or accompanied by stock transfer <del>powers; (d) through</del>  <ins>powers, provided that, the acceptance of such shares in payment of the Exercise Price will not result in adverse accounting consequences to the Company; (d)through</ins> simultaneous sale through a broker acceptable to the Committee of shares of Common Stock issuable to the Consultant on exercise, as permitted under Regulation T of the Board of Governors of the Federal Reserve System.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/marker-therapeutics-inc-2050/contract/277076/#clause-id-580381"}]}
{"clause_number": "Clause 6", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Holder, at its election, may either pay the Exercise Price in immediately available funds, or satisfy its obligation to pay the Exercise Price through a \"cashless exercise,\" in which event the Company shall issue to the Holder the number of Warrant Shares determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the Current Market Price (as of the <del>Exerc</del><ins>date of such calculation)</ins> of one share of Common Stock. B = the Exercise Price (as adjusted to the <del>Exercise Date). 10</del>  <ins>date of such calculation).</ins> For purposes of this Warrant, the \"Current Market Price\" of one share of <ins>the Company's</ins> Common Stock as of <del>the Exercise Date</del>  <ins>a particular date</ins> shall be determined as follows: (a) if traded on a national securities exchange, the Current Market Price shall be deemed to be the arithmetic average of the VWAPs for the five (5) consecutive Trading Days immediately preceding the <del>Exercise Date;</del>  <ins>applicable date;</ins> (b) if traded over-the-counter but not on the Nasdaq Stock Market, the Current Market Price shall be deemed to be the average of the closing bid and asked prices <del>for the</del>  <ins>as of</ins> five (5) <del>Trading</del>  <ins>Business</ins> Days immediately <del>preceding</del>  <ins>prior to the date of exercise indicated in</ins> the Exercise <del>Date;</del>  <ins>Notice;</ins> and (c) if there is no active public market, the Current Market Price shall be the fair market value of the Common Stock as of the <del>Exercise Date,</del>  <ins>date of exercise,</ins> as determined by an independent appraiser selected in good faith by the Holder. <ins>10</ins> For purposes of Rule 144, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the Issuance Date.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/falconstor-software-inc-7768/contract/501851/#clause-id-1129147", "variations": []}
{"clause_number": "Clause 7", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The exercise price shall be payable in whole or in part in cash, Shares held by Employee, other property, or such other consideration consistent with the Agreement's purpose and applicable law as may be determined by the Administrator from time to time. Except as otherwise determined by the Administrator at the time of grant, such price shall be paid in cash in full at the time that the Option is exercised. If Employee is permitted by the Administrator to pay all or a part of the exercise pricein Shares and elects to do so, Employee may make such payment by delivering to the Company a number of Shares, either directly or by attestation, which are equal in value to the purchase or exercise price hereunder. For this purpose, all Shares so delivered shall be valued per share at the Fair Market Value (as defined above; provided, however, if a Share is not susceptible to valuation by the above method, the term \"Fair Market Value\" of a Share shall mean the fair market value of a Share as the Administrator may determine in conformity with pertinent law) of a Share on the business day immediately preceding the day on which such Shares are delivered.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/ensync-inc-2278/contract/401007/#clause-id-857053", "variations": [{"variation_number": "Variation 1", "text": "Payment of Exercise Price. The exercise price shall be payable in whole or in part in cash, Shares held by Employee, other property, or such other consideration consistent with the Agreement's purpose and applicable law as may be determined by the Administrator from time to time. Except as otherwise determined by the Administrator at the time of grant, such price shall be paid in cash in full at the time that the Option is exercised. If Employee is permitted by the Administrator to pay all or a part of the exercise pricein Shares and elects to do so, Employee may make such payment by delivering to the Company a number of Shares, either directly or by attestation, which are equal in value to the purchase or exercise price hereunder. For this purpose, all Shares so delivered shall be valued per share at the Fair Market Value (as defined above; provided, however, if a Share is not susceptible to valuation by the above method, the term \"Fair Market Value\" of a Share shall mean the fair market value of a Share as the Administrator may determine in conformity with pertinent law) of a Share on the business day immediately preceding the day on which such Shares are delivered.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/ensync-inc-2278/contract/401007/#clause-id-857053"}, {"variation_number": "Variation 2", "text": "Payment of Exercise Price. The exercise price shall be payable in whole or in part in cash, Shares held by <del>Employee,</del>  <ins>Grantee,</ins> other property, or such other consideration consistent with the Agreement's purpose and applicable law as may be determined by the Administrator from time to time. Except as otherwise determined by the Administrator at the time of grant, such price shall be paid in cash in full at the time that the Option is exercised. If <del>Employee</del>  <ins>Grantee</ins> is permitted by the Administrator to pay all or a part ofthe exercise price in Shares and elects to do so, <del>Employee</del>  <ins>Grantee</ins> may make such payment by delivering to the Company a number of Shares, either directly or by attestation, which are equal in value to the purchase or exercise price hereunder. For this purpose, all Shares so delivered shall be valued per share at the Fair Market <del>Value (as defined above; provided, however, if a Share is not susceptible to valuation by the above method, the term \"Fair Market Value\" of a Share shall mean the fair market value of a Share as the Administrator may determine in conformity with pertinent law) of a Share on the business day immediately preceding the day on which such Shares are delivered.</del>  <ins>Value.</ins>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/energous-corp-4483/contract/427184/#clause-id-931247"}, {"variation_number": "Variation 3", "text": "Payment of Exercise Price. The exercise price shall be payable in whole or in part in cash, Shares held by <del>Employee,</del>  <ins>Grantee,</ins> other property, or such other consideration consistent with the Agreement's purpose and applicable law as may be determined by the Administrator from time to time. Except as otherwise determined by the Administrator at the time of grant, such price shall be paid in cash in full at the time that the Option is exercised. If <del>Employee</del>  <ins>Grantee</ins> is permitted by the Administrator to pay all or a part ofthe exercise price in Shares and elects to do so, <del>Employee</del>  <ins>Grantee</ins> may make such payment by delivering to the Company a number of Shares, either directly or by attestation, which are equal in value to the purchase or exercise price hereunder. For this purpose, all Shares so delivered shall be valued per share at the Fair Market Value (as defined above; provided, however, if a Share is not susceptible to valuation by the above method, the term \"Fair Market Value\" of a Share shall mean the fair market value of a Share as the Administrator may determine in conformity with pertinent law) of a Share on the business day immediately preceding the day on which such Shares are delivered.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/wafergen-bio-systems-inc-18539/contract/479166/#clause-id-1072104"}]}
{"clause_number": "Clause 8", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. (a) Payment Options. The exercise price <ins>(together with any Option Tax Liability and Secondary NIC Liability)</ins> shall be paid by one or any combination of the following forms of payment that are applicable to this option, as indicated on the cover page hereof: <del>(i) by check</del>  <ins>(i)by cheque</ins> payable to the order of the Company; or <del>(ii) if</del>  <ins>(ii)provided that</ins> the <ins>Company's</ins> Common Stock is then <del>traded</del>  <ins>listed</ins> on a <del>national</del> securities <del>exchange</del>  <ins>exchange, including the Nasdaq Global Market,</ins> or on the <del>Nasdaq Nati</del><ins>Over-the-Counter Bulletin Board,</ins> by delivery of an irrevocable and unconditional undertaking, satisfactory in form and substance to the Company, by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price, or delivery by the Optionee to the Company of a copy of irrevocable and unconditional instructions, satisfactory in form and substance to the Company, to a creditworthy broker to deliver promptly to the Company cash or a <del>check</del>  <ins>cheque</ins> sufficient to pay the exercise price.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/eurosite-power-inc-20636/contract/446842/#clause-id-988735", "variations": []}
{"clause_number": "Clause 9", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. <del>In the event of a Cash Exercise, the</del>  <ins>The</ins> Holder shall pay the Aggregate Exercise Price by paying, in lawful money of the United States, <del>by wire transfer,</del>  <ins>in</ins> certified check or bank draft payable to the order of the <del>Warrant Agent</del>  <ins>Company</ins> (or as otherwise agreed to by the Company) delivered to the Warrant Agent together with the <ins>Warrant Certificate and</ins> Form of Election to Purchase. <del>A registered Holder may exercise the Warrants through a Cashless Exercise on the terms and subject to the conditions</del>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/microvision-inc-6818/contract/449604/#clause-id-995910", "variations": []}
{"clause_number": "Clause 10", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Company will provide and communicate to the Participant various methods of exercise. In all cases, upon exercise, the Participant must deliver or cause to be delivered to the Company (or its agent designated for the purpose) upon settlement of the exercise sufficient cash or sufficient number of Shares with value equal to or exceeding the Exercise Price per Share. The Participant also is required to deliver or cause to be delivered sufficient cash to cover the applicable tax withholding in accordance with Section 5 of this Agreement and fees in connection with the exercise. To facilitate exercise, the Company may enter into agreements for coordinated procedures with one or more brokerage firms or financial institutions.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/estee-lauder-cos-482/contract/68963/#clause-id-126984", "variations": [{"variation_number": "Variation 1", "text": "Payment of Exercise Price. The Company will provide and communicate to the Participant various methods of exercise. In all cases, upon exercise, the Participant must deliver or cause to be delivered to the Company (or its agent designated for the purpose) upon settlement of the exercise sufficient cash or sufficient number of Shares with value equal to or exceeding the Exercise Price per Share. The Participant also is required to deliver or cause to be delivered sufficient cash to cover the applicable tax withholding inaccordance with Section 5 of this Agreement and fees in connection with the exercise. To facilitate exercise, the Company may enter into agreements for coordinated procedures with one or more brokerage firms or financial institutions.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/estee-lauder-cos-482/contract/68963/#clause-id-126984"}]}
{"clause_number": "Clause 11", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Holder shall pay the Exercise Price in immediately available funds. 7 11. Fractional Shares. The Company shall not be required to issue or cause to be issued fractional Warrant Shares on the exercise of this Warrant. If any fraction of a Warrant Share would, except for the provisions of this Section, be issuable upon exercise of this Warrant, the number of Warrant Shares to be issued will be rounded up to the nearest whole share.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/isign-solutions-inc-8751/contract/382853/#clause-id-817856", "variations": [{"variation_number": "Variation 1", "text": "Payment of Exercise Price. The Holder shall pay the Exercise Price in immediately available funds. 7 11. Fractional Shares. The Company shall not be required to issue or cause to be issued fractional Warrant Shares on the exercise of this Warrant. If any fraction of a Warrant Share would, except for the provisions of this Section, be issuable upon exercise of this Warrant, the number of Warrant Shares to be issued will be rounded up to the nearest whole share.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/isign-solutions-inc-8751/contract/382853/#clause-id-817856"}, {"variation_number": "Variation 2", "text": "Payment of Exercise Price. The Holder shall pay the Exercise Price in immediately available funds. <del>7 11.</del>  <ins>6 10.</ins> Fractional Shares. The Company shall not be required to issue or cause to be issued fractional Warrant Shares on the exercise of this Warrant. If any fraction of a Warrant Share would, except for the provisions of this Section, be issuable upon exercise of this Warrant, the number of Warrant Shares to be issued will be rounded up to the nearest whole share.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/sibling-group-holdings-inc-19530/contract/480748/#clause-id-1076062"}]}
{"clause_number": "Clause 12", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. Except in the case of a Cashless Exercise pursuant to subsection 4(b) above, the Holder shall pay the Aggregate Exercise Price by paying, in lawful money of the United States, by certified check payable to the Warrant Agent, as agent for the Company, or bank draft payable to the order of the Company or by wire transfer of immediately available funds to an account designated in writing by the Company (or as otherwise agreed to by the Company) delivered to the Warrant Agent not later than one Trading Day after the Date of Exercise.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/dnib-unwind-inc-9259/contract/414304/#clause-id-892589", "variations": [{"variation_number": "Variation 1", "text": "Payment of Exercise Price. Except in the case of a Cashless Exercise pursuant to subsection 4(b) above, the Holder shall pay the Aggregate Exercise Price by paying, in lawful money of the United States, by certified check payable to the Warrant Agent, as agent for the Company, or bank draft payable to the order of the Company or by wire transfer of immediately available funds to an account designated in writing by the Company (or as otherwise agreed to by the Company) delivered to the Warrant Agent not later than oneTrading Day after the Date of Exercise.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/dnib-unwind-inc-9259/contract/414304/#clause-id-892589"}, {"variation_number": "Variation 2", "text": "Payment of Exercise Price. <del>Except in the case of a Cashless Exercise pursuant to subsection 4(b) above, the</del>  <ins>The</ins> Holder shall pay the Aggregate Exercise Price by paying, in lawful money of the United States, by certified check payable to the Warrant Agent, as agent for the Company, or bank draft payable to the order of the Company or by wire transfer of immediately available funds to an account designated in writing by the Company (or as otherwise agreed to by the Company) delivered to the Warrant Agent not later than oneTrading Day after the Date of Exercise. <ins>Notwithstanding the foregoing, if payment is made in any form other than a wire transfer of immediately available funds, neither the Warrant Agent nor the Company shall be required to issue Warrant Shares until the Warrant Agent's bank shall have confirmed that the payment has cleared, which date shall be the date that the Holder has made payment of the Exercise Price.</ins>", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/grom-social-enterprises-inc-5435/contract/184383/#clause-id-383093"}]}
{"clause_number": "Clause 13", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless exercise,\" in which event the Company shall issue to the Holder the number of Warrant Shares determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the average of the Closing Sale Prices of the shares of Common Stock (as reported by Bloomberg Financial Markets) for the five (5) consecutive Trading Days ending on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). Except as set forth in Section 5(b) (Buy-In remedy) and Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/syndax-pharmaceuticals-inc-3218/contract/91105/#clause-id-172965", "variations": []}
{"clause_number": "Clause 14", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless exercise\", in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, as determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale Prices of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). In the event that the Registration Statement or another registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10. Except as set forth in Section 5(b) (Buy-In remedy) and Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/chiasma-inc-2880/contract/106698/#clause-id-197482", "variations": []}
{"clause_number": "Clause 15", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Exercise Price shall be paid in cash or in such other manner as determined in accordance with the Plan.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/ayala-pharmaceuticals-inc-10158/contract/114046/#clause-id-212844", "variations": []}
{"clause_number": "Clause 16", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless exercise\", in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, as determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale Prices of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). In the event that a registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10. In no event will the exercise of this Warrant be settled in cash.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/achieve-life-sciences-inc-7894/contract/116351/#clause-id-217086", "variations": []}
{"clause_number": "Clause 17", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. To exercise all or a portion of this Award, you must pay the Exercise Price for each Share. You may pay the Exercise Price by using one or more of the following methods: (A) in cash or by certified check, bank draft, wire transfer or postal or express money order; (B) by delivering a properly executed exercise notice to the Company or its agent, together with irrevocable instructions to a broker to deliver promptly to the Company, within the typical settlement cycle for the sale of equity securities on the relevant trading market (or otherwise in accordance with Regulation T issued by the United States Board of Governors of the Federal Reserve System), the amount of sale proceeds with respect to the portion of the Shares to be acquired having a Fair Market Value on the date of exercise equal to the sum of the applicable portion of the Exercise Price being so paid; (C) by tendering (actually or by attestation) to the Company or its agent previously acquired Shares that have a Fair Market Value on the day prior to the date of exercise equal to the applicable portion of the Exercise Price being so paid; or (D) by instructing the Company to reduce the number of Shares that would otherwise be issued upon exercise by such number of Shares as have in the aggregate a Fair Market Value on the date of exercise equal to the applicable portion of the Exercise Price being so paid. Notwithstanding the foregoing, you may not tender any form of payment or exercise this Award by any method that the Company determines, in its sole discretion, could violate any applicable law, regulation or Company policy. You are not required to purchase all Shares subject to this Award at one time, but you must pay the full Exercise Price by a means satisfactory to the Company for all Shares that you elect to purchase before they will be delivered. This Stock Option may not be exercised for fractional Shares. The date of exercise of a Stock Option shall be the date on which the Company receives the Exercise Price for such the Shares being exercised. Notwithstanding anything in this Section 5 to the contrary, if this Award is scheduled to expire due to the expiration of the term on the date described in Section 4 above and the Fair Market Value of a Share on the last day of such term exceeds the Exercise Price for a Share subject to this Award, then, by accepting this Award, you agree that, unless you notify the Company's third-party administrator (currently E*Trade) at least ten (10) business days before such expiration date that you do not wish for this Award to be exercised, you shall be treated as having instructed the Company to exercise the vested portion of this Award on the last day of such term and to pay the Exercise Price by application of the method described in (D) above or such other method as determined by the Company, provided that such method complies with applicable law. 6.Exercise of Stock Option. If you are entitled to exercise this Award, you may exercise it by contacting E*Trade through its web site at www.etrade.com or by calling 1-800-838-0908. If someone other than you attempts to exercise Shares subject to this Award (for example, because the Stock Option is being exercised after your death), the Company will deliver the Shares only after determining that the person attempting to exercise Stock Option subject to this Award is your duly appointed personal representative or an individual to whom this Award has been transferred in accordance with these Terms and Conditions and the terms of the Plan.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/gcp-applied-technologies-inc-5242/contract/131575/#clause-id-253023", "variations": []}
{"clause_number": "Clause 18", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. When you submit your notice of exercise, you must include payment of the exercise price of the Shares being purchased through one or a combination of the following methods: (a) Cash or by promissory note; (b) By means of a broker-assisted cashless exercise in which you irrevocably instruct your broker to deliver proceeds of a sale of all or a portion of the Shares to be issued pursuant to the exercise to the Company in payment of the exercise price of such Shares; (c) By delivery to the Companyof Shares (by actual delivery or attestation of ownership in a form approved by the Company) already owned by you that are not subject to any security interest and that have an aggregate Fair Market Value on the date of exercise equal to the exercise price of the Shares being purchased; or (d) By authorizing the Company to retain, from the total number of Shares as to which the Option is being exercised, that number of Shares having a Fair Market Value on the date of exercise equal to the exercise price for the total number of Shares as to which the Option is being exercised.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/audioeye-inc-3006/contract/141929/#clause-id-278592", "variations": []}
{"clause_number": "Clause 19", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. The Holder may notify the Company in an Exercise Notice of its election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant Units determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the daily volume weighted average price for the Common Stock for the five Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise Price. 5 For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/crown-electrokinetics-corp-8596/contract/147009/#clause-id-292941", "variations": []}
{"clause_number": "Clause 20", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless exercise\", in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, as determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale Prices of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. Except as set forth in Section 5(b) (Buy-In remedy) and Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/altimmune-inc-2816/contract/158017/#clause-id-321400", "variations": []}
{"clause_number": "Clause 21", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. Payment of the Option exercise price must be made in full pursuant to any of the following procedures or such other electronic or other procedures as may be specified by the Corporation or the Committee from time to time: (i) in cash, by check or cash equivalent, (ii) by delivery to the Corporation of unencumbered shares of Common Stock owned by the Participant having a Fair Market Value not less than the exercise price, (iii) delivery by attestation to the Corporation by the Participant of ownership of shares of Common Stock having a Fair Market Value not less than the exercise price accompanied by a request and authorization to the Corporation to deliver to the Participant upon exercise only the number of whole shares by which the number of shares covered by the Option being exercised exceeds the number of shares stated in such attestation; (iv) by delivery to the Corporation by a broker of cash equal to the exercise price of the Option upon an undertaking by the Participant to cause the Corporation to deliver to the broker some or all of the shares being acquired upon the exercise of the Option (a \"Cashless Exercise\"), (v) by a \"net exercise\" arrangement pursuant to which the Corporation will reduce the number of shares of Common Stock issued upon exercise of the Option by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price and the Participant shall deliver to the Corporation a cash or other payment to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of whole shares to be issued; (vi) by such other consideration as may be approved by the Committee from time to time to the extent permitted by applicable law, or (vii) by any combination of the foregoing. The Committee may at any time or from time to time grant Options which permit only some of the foregoing forms of consideration to be used in payment of the 8 exercise price or which otherwise restrict the use of one or more forms of consideration. The number of shares of Common Stock covered by, and available for exercise under, a Participant's Options shall be reduced by (A) shares covered by an attestation used for netting in accordance with clause (iii) above; (B) shares used to pay the exercise price pursuant to a \"net exercise\" in accordance with clause (v) above; (C) shares delivered to the Participant as a result of any exercise, and (D) shares withheld to satisfy tax withholding obligations.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/dover-corp-418/contract/177800/#clause-id-365250", "variations": []}
{"clause_number": "Clause 22", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. (a) Payment Options. The exercise price and any required withholding taxes may be paid by one or any combination of the following forms of payment that are applicable to this option, as indicated on the cover page hereof: (i) by check payable to the order of the Company; (ii) if the Common Stock is then publicly traded, delivery of an irrevocable and unconditional undertaking, satisfactory in form and substance to the Company, by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price and any required tax withholding; or delivery by the Optionee to the Company of a copy of irrevocable and unconditional instructions, satisfactory in form and substance to the Company, to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price and any required tax withholding; 5 (iii) subject to Section 8(b) below, if the Common Stock is then traded on a national securities exchange or another national trading system, by delivery of shares of Common Stock having a fair market value equal as of the date of exercise to the exercise price and any required tax withholding; (iv) at the discretion of the Company's Board of Directors and in compliance with the Sarbanes-Oxley Act of 2002, as amended, by delivery of the Optionee's personal recourse note bearing interest payable not less than annually at no less than 100% of the applicable Federal rate, as defined in Section 1274(d) of the Code; or (v) by any combination of the foregoing equal in amount to the Exercise Price. In the case of (iii) above, fair market value as of the date of exercise shall be determined as of the last business day for which such prices or quotes are available prior to the date of exercise and shall mean (i) the last reported sale price (on that date) of the Common Stock on the principal national securities exchange on which the Common Stock is traded, if the Common Stock is then traded on a national securities exchange; or (ii) the last reported sale price (on that date) of the Common Stock on another national trading system, if the Common Stock is not then traded on a national securities exchange. (b) Limitations on Payment by Delivery of Common Stock. If Section 8(a)(iii) is applicable, and if the Optionee delivers Common Stock held by the Optionee (\"Old Stock\") to the Company in full or partial payment of the exercise price and required tax withholding and the Old Stock so delivered is subject to restrictions or limitations imposed by agreement between the Optionee and the Company, a number of Shares shall be subject to all restrictions and limitations applicable to the Old Stock to the extent that the Optionee paid for the Shares by delivery of Old Stock, in addition to any restrictions or limitations imposed by this Agreement.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/cyteir-therapeutics-inc-13084/contract/181002/#clause-id-373263", "variations": []}
{"clause_number": "Clause 23", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless exercise\", in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, as determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale Price of the shares of Common Stock (as reported by Bloomberg Financial Markets) on the Trading Day immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). In the event that a registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10. Except as set forth in Section 5(b) (Buy-In remedy), Section 9(b) (Pro Rata Distributions), Section 9(c) (Fundamental Transactions) and Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/bluebird-bio-inc-2661/contract/197639/#clause-id-415881", "variations": []}
{"clause_number": "Clause 24", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless exercise,\" in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, determined as follows: X = Y [(A-B)/A]where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale Price of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the SEC continues to take the position that such treatment is proper at the time of such exercise). In the event that a registration statement registering the issuance of the Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10. If Warrant Shares are issued in such a cashless exercise, the Company acknowledges and agrees that, in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrants being exercised may be tacked on to the holding period of the Warrant Shares (provided that the SEC continues to take the position that such treatment is proper at the time of such exercise).", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/arsanis-inc-3909/contract/206968/#clause-id-440302", "variations": []}
{"clause_number": "Clause 25", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless exercise\", in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, as determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale Price of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). In the event that the Registration Statement or another registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10. Except as set forth in Section 5(b) (Buy-In remedy) and Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/sierra-oncology-inc-2647/contract/218978/#clause-id-473492", "variations": []}
{"clause_number": "Clause 26", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless exercise,\" in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale Price of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the SEC continues to take the position that such treatment is proper at the time of such exercise). In the event that a registration statement registering the issuance of the Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10. Except as set forth in Section 5(b) (Buy-In remedy) and Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/syros-pharmaceuticals-inc-4295/contract/245435/#clause-id-520384", "variations": []}
{"clause_number": "Clause 27", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. The Holder may notify the Company in an Exercise Notice of its election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant Units determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the last traded price on the Trading Day immediately preceding the Exercise Date. B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued. -5- 12. Limitations on Exercise. Notwithstanding anything to the contrary contained herein, the number of Warrant Shares that may be acquired by the Holder upon any exercise of this Warrant (or otherwise in respect hereof) shall be limited to the extent necessary to insure that, following such exercise (or other issuance), the total number of shares of Common Stock then beneficially owned by such Holder and its Affiliates and any other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder's for purposes of Section 13(d) of the Exchange Act, does not exceed 9.99% of the total number of issued and outstanding shares of Common Stock (including for such purpose the shares of Common Stock issuable upon such exercise). For such purposes, beneficial ownership shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. This provision shall not restrict the number of shares of Common Stock which a Holder may receive or beneficially own in order to determine the amount of securities or other consideration that such Holder may receive in the event of a Fundamental Transaction as contemplated in Section 9 of this Warrant. This restriction may not be waived. Notwithstanding anything to the contrary contained in this Warrant, (a) no term of this Section may be waived by any party, nor amended such that the threshold percentage of ownership would be directly or indirectly increased, (b) this restriction runs with the Warrant and may not be modified or waived by any subsequent holder hereof and (c) any attempted waiver, modification or amendment of this Section will be void ab initio.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/nft-gaming-co-inc-15364/contract/267978/#clause-id-565182", "variations": []}
{"clause_number": "Clause 28", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless exercise,\" in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act as determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals (i) the last Closing Sale Price of the shares of Common Stock (as reported by Bloomberg) on the Trading Day immediately preceding the Exercise Date if the Exercise Notice is delivered prior to market close on the Exercise Date, or (ii) the last Closing Sale Price of the shares of Common Stock (as reported by Bloomberg) on the Exercise Date if the Exercise Notice is delivered following market close on the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). In the event that the Registration Statement or another registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10. Except as set forth in Section 5(b) (Buy-In remedy) and Section 12 (payment of cash in lieu of fractional shares), in no event will the exercise of this Warrant be settled in cash. For the avoidance of doubt, in the event that the Registration Statement or another registration statement registering the issuance of the Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then a cashless exercise pursuant to this Section 10 in exchange for unregistered Warrant Shares in accordance with Section 3(a)(9) of the Securities Act shall also be permitted.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/apellis-pharmaceuticals-inc-3820/contract/271051/#clause-id-570238", "variations": []}
{"clause_number": "Clause 29", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. When you submit your notice of exercise, you must include payment of the exercise price of the Shares being purchased through one or a combination of the following methods: 2 (a) Cash (including personal check, cashier's check or money order); (b) By means of a broker-assisted cashless exercise in which you irrevocably instruct your broker to deliver proceeds of a sale of all or a portion of the Shares to be issued pursuant to the exercise to the Company in payment of the exercise price of suchShares; or (c) By delivery to the Company of Shares (by actual delivery or attestation of ownership in a form approved by the Company) already owned by you that are not subject to any security interest and that have an aggregate Fair Market Value on the date of exercise equal to the exercise price of the Shares being purchased; or (d) By authorizing the Company to retain, from the total number of Shares as to which the Option is being exercised, that number of Shares having a Fair Market Value on the date of exercise equal to the exercise price for the total number of Shares as to which the Option is being exercised.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/insignia-systems-inc-7485/contract/294582/#clause-id-624621", "variations": []}
{"clause_number": "Clause 30", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. This Warrant shall be exercised for cash; provided, however, that if at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained therein is not available for, the issuance of the Warrant Shares, then the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless exercise\", in which event the Company shall issue to the Holder the number of Warrant Shares in an exchange of securities effected pursuant to Section 3(a)(9) of the Securities Act, as determined as follows: X = Y [(A-B)/A] where: \"X\" equals the number of Warrant Shares to be issued to the Holder; \"Y\" equals the total number of Warrant Shares with respect to which this Warrant is then being exercised; \"A\" equals the Closing Sale Prices of the shares of Common Stock (as reported by Bloomberg Financial Markets) as of the Trading Day on the date immediately preceding the Exercise Date; and \"B\" equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a \"cashless exercise\" transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise). In the event that the Registration Statement or another registration statement registering the issuance of Warrant Shares is, for any reason, not effective at the time of exercise of this Warrant, then the Warrant may only be exercised through a cashless exercise, as set forth in this Section 10. Except as set forth in Section 5(b) (Buy-In remedy) and Section 12 (payment of cash in lieu of fractional shares), under such circumstances in no event will the exercise of this Warrant be settled in cash.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/evofem-biosciences-inc-4988/contract/302052/#clause-id-642644", "variations": []}
{"clause_number": "Clause 31", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Holder shall pay the Exercise Price in immediately available funds; provided, however, that if an effective registration statement covering the issuance or resale of the Warrant Shares is not available for such purpose, the Holder, then, at the Holder's option, may exercise this Warrant in whole or in part, at such time by means of a \"cashless exercise,\" in which event the Company shall issue to the Holder the number of Warrant Shares determined as follows: X = Y[(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the total number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the Closing Bid Price of the shares of Common Stock (as reported by Bloomberg Financial Markets) for the five consecutive Trading Days ending on the date immediately preceding the Exercise Date. B = the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of this Warrant, \"Closing Bid Price\" means, for any security as of any date, the last reported closing bid price for such security on the Principal Trading Market for such security, as reported by Bloomberg Financial Markets, or, if such Principal Trading Market begins to operate on an extended hours basis and does not designate the closing bid price, then the last bid price of such security prior to 4:00 p.m., New York City time, as reported by Bloomberg Financial Markets, or if the foregoing do not apply, the last closing price of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg Financial Markets, or, if no closing bid price is reported for such security by Bloomberg Financial Markets, the average of the bid prices of any market makers for such security as reported on OTC Pink (also known as the \"pink sheets\") by the OTC Markets. If the Closing Bid Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Bid Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then the Board of Directors of the Company shall use its good faith judgment to determine the fair market value. The Board of Directors' determination shall be binding upon all parties absent demonstrable error. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period. For purposes of Rule 144, it is intended, understood and acknowledged that the provisions above permitting \"cashless exercise\" under certain circumstances are intended, in part, to ensure that a full or partial exchange of this Warrant pursuant to such provisions will qualify as a conversion, within the meaning of paragraph (d)(3)(ii) of Rule 144, and the holding period for the Warrant Shares shall be deemed to have commenced as to such original Holder, on the Original Issue Date.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/quicklogic-corporation-7535/contract/306566/#clause-id-656539", "variations": []}
{"clause_number": "Clause 32", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Holder, at its election, may either pay the Exercise Price in immediately available funds, or satisfy its obligation to pay the Exercise Price through a \"cashless exercise,\" in which event the Company shall issue to the Holder the number of Warrant Shares determined as follows: 10 X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the Current Market Price (as of the Exercise Date) of one share of Common Stock. B = the Exercise Price (as adjusted to the Exercise Date). For purposes of this Warrant, the \"Current Market Price\" of one share of Common Stock as of the Exercise Date shall be determined as follows: (a) if traded on a national securities exchange, the Current Market Price shall be deemed to be the arithmetic average of the VWAPs for the five (5) consecutive Trading Days immediately preceding the Exercise Date; (b) if traded over-the-counter but not on the Nasdaq Stock Market, the Current Market Price shall be deemed to be the average of the closing bid and asked prices for the five (5) Trading Days immediately preceding the Exercise Date; and (c) if there is no active public market, the Current Market Price shall be the fair market value of the Common Stock as of the Exercise Date, as determined by an independent appraiser selected in good faith by the Holder. For purposes of Rule 144, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the Issuance Date.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/falconstor-software-inc-7768/contract/319657/#clause-id-690098", "variations": []}
{"clause_number": "Clause 33", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. (a) Payment Options. The exercise price shall be paid by one or any combination of the following forms of payment that are applicable to this Option, as indicated on the cover page hereof: (i) by check payable to the order of the Company; or (ii) if the Common Stock is then traded on a national securities exchange or on the Nasdaq Capital Market (or successor trading system), delivery of an irrevocable and unconditional undertaking, satisfactory in form and substance to the Company, by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price, or delivery by the Optionee to the Company of a copy of irrevocable and unconditional instructions, satisfactory in form and substance to the Company, to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price; or (iii) subject to Section 7(b) below, if the Common Stock is then traded on a national securities exchange or on the Nasdaq Capital Market (or successor trading system), by delivery of shares of Common Stock having a fair market value equal as of the date of exercise to the option price; or (iv) by check payable to the order of the Company for the par value of the shares being purchased plus delivery of the Optionee's three-year personal full recourse promissory note for the balance of the exercise price, with such note bearing interest payable not less than annually at the applicable Federal rate, as defined in Section 1274(d) of the Code. In the case of (iii) above, fair market value as of the date of exercise shall be determined as of the last business day for which such prices or quotes are available prior to the date of exercise and shall mean (i) the last reported sale price (on that date) of the Common Stock on the principal national securities exchange on which the Common Stock is traded. if the Common Stock is then traded on a national securities exchange; or (ii) the last reported sale price (on that date) of the Common Stock on the Nasdaq Capital Market (or successor trading system), if the Common Stock is not then traded on a national securities exchange. (b) Limitations on Payment by Delivery of Common Stock. If Section 7(a)(iii) is applicable, and if the Optionee delivers Common Stock held by the Optionee (\"Old Stock\") to the Company in full or partial payment of the exercise price and the Old Stock so delivered is subject to restrictions or limitations imposed by agreement between the Optionee and the Company, an equivalent number of Shares shall be subject to all restrictions and limitations applicable to the Old Stock to the extent that the Optionee paid for the Shares by delivery of Old Stock, in addition to any restrictions or limitations imposed by this agreement. Notwithstanding the foregoing, the Optionee may not pay any part of the exercise price hereof by transferring Common Stock to the Company unless such Common Stock has been owned by the Optionee free of any substantial risk of forfeiture for at least six months.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/artemis-therapeutics-inc-1872/contract/334270/#clause-id-723527", "variations": []}
{"clause_number": "Clause 34", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. 3.1Forms of Consideration Authorized. 3.2Limitations on Forms of Consideration.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/extreme-networks-inc-499/contract/335289/#clause-id-725611", "variations": []}
{"clause_number": "Clause 35", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Option represented hereby may be exercised in whole or in part by Participant delivering to the Company payment of the Exercise Price for the number of the Option so exercised: (i) in cash, by check or cash equivalent; (ii) by tender to the Company of shares of Stock owned by the Participant having a Fair Market Value not less than the exercise price for the number of the Option exercised; (iii) by tender to the Company of a written consent to accept a reduction in the number of Shares of Stock issuable upon exercise (\"Reduced Number of Shares\"), which Reduced Number of Shares, when ascribed a value, shall have a value equal to the Exercise Price for the number of the Option exercised; (iv) by delivery of a properly executed notice of exercise together with irrevocable instructions to a broker providing for the assignment to the Company of the proceeds of a sale or loan with respect to some or all of the Shares being acquired upon the exercise of the Option or portion thereof exercised (including, without limitation, through an exercise complying with the provisions of Regulation T as promulgated from time to time by the Board of Governors of the Federal Reserve System) (a \"Cashless Exercise\"); (v) by such other consideration as may be approved by the Committee from time to time to the extent permitted by applicable law; or (vi) by any combination thereof. The Company reserves, at any and all times, the right, in the Company's sole and absolute discretion, to establish, decline to approve or terminate any program or procedures for the exercise of the Option by means of a Cashless Exercise.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/lapolla-industries-inc-19811/contract/342753/#clause-id-742168", "variations": []}
{"clause_number": "Clause 36", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Holder shall pay the Exercise Price in immediately available funds; provided, however, the Holder may, in its sole discretion, commencing on the date that is 18 months from the date of this Warrant, satisfy its obligation to pay the Exercise Price through a \"cashless exercise\", in which event the Company shall issue to the Holder the number of Warrant Shares determined as follows: 5 X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the total number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the Closing Sale Prices of the shares of Common Stock (as reported by Bloomberg Financial Markets) for the five Trading Days ending on the date immediately preceding the Exercise Date. B = the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of this Warrant, \"Closing Sale Price\" means, for any security as of any date, the last trade price for such security on the principal securities exchange or trading market for such security, as reported by Bloomberg Financial Markets, or, if such exchange or trading market begins to operate on an extended hours basis and does not designate the last trade price, then the last trade price of such security prior to 4:00:00 p.m., New York Time, as reported by Bloomberg Financial Markets, or if the foregoing do not apply, the last trade price of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg Financial Markets, or, if no last trade price is reported for such security by Bloomberg Financial Markets, the average of the bid prices, or the ask prices, respectively, of any market makers for such security as reported in the \"pink sheets\" by Pink Sheets LLC. If the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then the Company shall, within two business days submit via facsimile (a) the disputed determination of the Warrant Exercise Price to an independent, reputable investment bank selected by the Company and approved by the Holder or (b) the disputed arithmetic calculation of the Warrant Shares to the Company's independent, outside accountant. The Company shall cause at its expense the investment bank or the accountant, as the case may be, to perform the determinations or calculations and notify the Company and the Holder of the results no later than ten business days from the time it receives the disputed determinations or calculations. Such investment bank's or accountant's determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error. All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period. 6 For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued pursuant to the Consulting Agreement (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise).", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/atomera-inc-3395/contract/351763/#clause-id-764717", "variations": []}
{"clause_number": "Clause 37", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. In lieu of a cash exercise pursuant to Section 10(a), the Holder may notify the Company in an Exercise Notice of its election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant Shares determined as follows (it being acknowledged, for the avoidance of doubt, that such Warrant Shares will be unregistered): 6 X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the daily volume weighted average price of the Common Stock for the five Trading Days immediately prior to (but not including) the Date of Exercise. B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued. For the avoidance of doubt, there is no circumstance that would require the Company to net cash settle the Warrant.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/delmar-pharmaceuticals-inc-3882/contract/356148/#clause-id-775924", "variations": []}
{"clause_number": "Clause 38", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Holder shall pay the Exercise Price in immediately available funds; provided, however, the Holder may, in its sole discretion, commencing on the Trigger Date and continuing until the date that is eighteen (18) months from the date of this Warrant, satisfy its obligation to pay the Exercise Price through a \"cashless exercise\", in which event the Company shall issue to the Holder the number of Warrant Shares determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the total number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the Closing Sale Prices of the shares of Common Stock (as reported by Bloomberg Financial Markets) for the five Trading Days ending on the date immediately preceding the Exercise Date. B = the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. For purposes of this Warrant, \"Closing Sale Price\" means, for any security as of any date, the last trade price for such security on the principal securities exchange or trading market for such security, as reported by Bloomberg Financial Markets, or, if such exchange or trading market begins to operate on an extended hours basis and does not designate the last trade price, then the last trade price of such security prior to 4:00:00 p.m., New York Time, as reported by Bloomberg Financial Markets, or if the foregoing do not apply, the last trade price of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg Financial Markets, or, if no last trade price is reported for such security by Bloomberg Financial Markets, the average of the bid prices, or the ask prices, respectively, of any market makers for such security as reported in the \"pink sheets\" by Pink Sheets LLC. If the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then the Company shall, within two business days submit via facsimile (a) the disputed determination of the Warrant Exercise Price to an independent, reputable investment bank selected by the Company and approved by the Holder or (b) the disputed arithmetic calculation of the Warrant Shares to the Company's independent, 5 outside accountant. The Company shall cause at its expense the investment bank or the accountant, as the case may be, to perform the determinations or calculations and notify the Company and the Holder of the results no later than ten business days from the time it receives the disputed determinations or calculations. Such investment bank's or accountant's determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error. All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued pursuant to the Purchase Agreement (provided that the Commission continues to take the position that such treatment is proper at the time of such exercise).", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/resonant-inc-4529/contract/364648/#clause-id-789585", "variations": []}
{"clause_number": "Clause 39", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Holder shall pay the Exercise Price in immediately available funds. 7 11. Fractional Shares. The Company shall not be required to issue or cause to be issued fractional Warrant Shares on the exercise of this Warrant. If any fraction of a Warrant Share would, except for the provisions of this Section, be issuable upon exercise of this Warrant, the number of Warrant Shares to be issued will be rounded up to the nearest whole share.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/isign-solutions-inc-8751/contract/382852/#clause-id-817848", "variations": []}
{"clause_number": "Clause 40", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. Options represented hereby may be exercised in whole or in part by delivering to the Company your payment of the Exercise Price for the number of Options so exercised (i) in cash, by check or cash equivalent, (ii) by tender to the Company of shares of Stock owned by the Participant having a Fair Market Value not less than the exercise price for the number of Options exercised; (iii) by tender to the Company of a written consent to accept a reduction in the number of shares of Stock issuable uponexercise (\"Reduced Number of Shares\"), which Reduced Number of Shares, when ascribed a value, shall have a value equal to the Exercise Price for the number of Options exercised; (iv) by delivery of a properly executed notice of exercise together with irrevocable instructions to a broker providing for the assignment to the Company of the proceeds of a sale or loan with respect to some or all of the shares being acquired upon the exercise of the Option or portion thereof exercised (including, without limitation, through an exercise complying with the provisions of Regulation T as promulgated from time to time by the Board of Governors of the Federal Reserve System) (a \"Cashless Exercise\"), (v) by such other consideration as may be approved by the Committee from time to time to the extent permitted by applicable law, or (vi) by any combination thereof. The Company reserves, at any and all times, the right, in the Company's sole and absolute discretion, to establish, decline to approve or terminate any program or procedures for the exercise of Options by means of a Cashless Exercise.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/lapolla-industries-inc-19811/contract/387064/#clause-id-823715", "variations": []}
{"clause_number": "Clause 41", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Company will provide and communicate to the Employee various methods of exercise. In all cases, upon exercise, the Employee must deliver or cause to be delivered to the Company (or its agent designated for the purpose) upon settlement of the exercise sufficient cash or sufficient number of Shares with value equal to or exceeding the Exercise Price per Share. The Employee also is required to deliver or cause to be delivered sufficient cash to cover the applicable tax withholding in accordancewith Section 5 of this Agreement and fees in connection with the exercise. To facilitate exercise, the Company may enter into agreements for coordinated procedures with one or more brokerage firms or financial institutions.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/estee-lauder-cos-482/contract/391947/#clause-id-833078", "variations": []}
{"clause_number": "Clause 42", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Holder shall pay the Exercise Price in immediately available funds; provided, however, that if, on any Exercise Date there is not an effective Registration Statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then the Holder may, in its sole discretion, satisfy its obligation to pay the Exercise Price through a \"cashless exercise\", in which event the Company shall issue to the Holder the number of Warrant Shares determined as follows:X = Y[(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the total number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the Closing Bid Price of the shares of Common Stock (as reported by Bloomberg Financial Markets) for the five consecutive Trading Days ending on the date immediately preceding the Exercise Date. B = the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise. 8 For purposes of this Warrant, \"Closing Bid Price\" means, for any security as of any date, the last reported closing bid price for such security on the Principal Trading Market for such security, as reported by Bloomberg Financial Markets, or, if such Principal Trading Market begins to operate on an extended hours basis and does not designate the closing bid price, then the last bid price of such security prior to 4:00 p.m., New York City time, as reported by Bloomberg Financial Markets, or if the foregoing do not apply, the last closing price of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg Financial Markets, or, if no closing bid price is reported for such security by Bloomberg Financial Markets, the average of the bid prices of any market makers for such security as reported on OTC Pink (also known as the \"pink sheets\") by the OTCMarkets. If the Closing Bid Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Bid Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then the Board of Directors of the Company shall use its good faith judgment to determine the fair market value. The Board of Directors' determination shall be binding upon all parties absent demonstrable error. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period. For purposes of Rule 144, it is intended, understood and acknowledged that the provisions above permitting \"cashless exercise\" are intended, in part, to ensure that a full or partial exchange of this Warrant pursuant to such provisions will qualify as a conversion, within the meaning of paragraph (d)(3)(ii) of Rule 144, and the holding period for the Warrant Shares shall be deemed to have commenced as to such original Holder, on the Original Issue Date.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/precipio-inc-1744/contract/394108/#clause-id-838555", "variations": []}
{"clause_number": "Clause 43", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The exercise price shall be payable in whole or in part in cash, Shares held by Employee, other property, or such other consideration consistent with the Agreement's purpose and applicable law as may be determined by the Administrator from time to time. Except as otherwise determined by the Administrator at the time of grant, such price shall be paid in cash in full at the time that the Option is exercised. If Employee is permitted by the Administrator to pay all or a part of the exercise pricein Shares and elects to do so, Employee may make such payment by delivering to the Company a number of Shares, either directly or by attestation, which are equal in value to the purchase or exercise price hereunder. For this purpose, all Shares so delivered shall be valued per share at the Fair Market Value (as defined above; provided, however, if a Share is not susceptible to valuation by the above method, the term \"Fair Market Value\" of a Share shall mean the fair market value of a Share as the Administrator may determine in conformity with pertinent law) of a Share on the business day immediately preceding the day on which such Shares are delivered.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/ensync-inc-2278/contract/401007/#clause-id-857053", "variations": []}
{"clause_number": "Clause 44", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. (a) Payment Options. The exercise price shall be paid by one or any combination of the following forms of payment that are applicable to this option, as indicated on the cover page hereof: (i)by check payable to the order of the Company; or (ii)provided that the Company's Common Stock is then listed on a securities exchange, including the Nasdaq Global Market, or on the Over-the-Counter Bulletin Board, by delivery of an irrevocable and unconditional undertaking, satisfactory in form and substance to the Company, by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price, or delivery by the Optionee to the Company of a copy of irrevocable and unconditional instructions, satisfactory in form and substance to the Company, to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price; or 8. Securities Laws Restrictions on Resale. Until registered under the Securities Act, the Shares will be illiquid and will be deemed to be \"restricted securities\" for purposes of the Securities Act. Accordingly, such shares must be sold in compliance with the registration requirements of the Securities Act or an exemption therefrom and may need to be held indefinitely. Unless the Shares have been registered under the Securities Act, each certificate evidencing any of the Shares shall bear a restrictive legend specified by the Company. American DG Energy Inc. ConfidentialStock Option Agreement 9. Method of Exercising Option. Subject to the terms and conditions of this agreement, this option may be exercised by written notice to the Company at its principal executive office, or to such transfer agent as the Company shall designate. Such notice shall state the election to exercise this option and the number of Shares for which it is being exercised and shall be signed by the person or persons so exercising this option. Such notice shall be accompanied by payment of the full purchase price of such shares, and the Company shall deliver a certificate or certificates representing such shares as soon as practicable after the notice shall be received. Such certificate or certificates shall be registered in the name of the person or persons so exercising this option (or, if this option shall be exercised by the Optionee and if the Optionee shall so request in the notice exercising this option, shall be registered in the name of the Optionee and another person jointly, with right of survivorship). In the event this option shall be exercised, pursuant to Section 5 hereof, by any person or persons other than the Optionee, such notice shall be accompanied by appropriate proof of the right of such person or persons to exercise this option.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/american-dg-energy-inc-18554/contract/404761/#clause-id-866041", "variations": []}
{"clause_number": "Clause 45", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. In the event of a Cash Exercise, the Holder shall pay the Aggregate Exercise Price by paying, in lawful money of the United States, by wire transfer, certified check or bank draft payable to the order of the Warrant Agent (or as otherwise agreed to by the Company) delivered to the Warrant Agent together with the Form of Election to Purchase. A registered Holder may exercise the Warrants through a Cashless Exercise on the terms and subject to the conditions set forth in Section 4. -14- 10. Holdernot Deemed a Stockholder. Except as otherwise specifically provided herein, the Holder, solely in such Person's capacity as a Holder, shall not be entitled to vote or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in the Warrants be construed to confer upon the Holder, solely in such Person's capacity as a Holder, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which such Person is then entitled to receive upon the due exercise of the Warrants.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/gevo-inc-3196/contract/407541/#clause-id-873531", "variations": []}
{"clause_number": "Clause 46", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. (a) Payment Options. The exercise price shall be paid by one or any combination of the following forms of payment that are applicable to this option, as indicated on the cover page hereof: (i) by check payable to the order of the Company; or (ii) if the Common Stock is then traded on a national securities exchange or on the Nasdaq National Market (or a successor trading system), by delivery of an irrevocable and unconditional undertaking, satisfactory in form and substance to the Company, by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price, or delivery by the Optionee to the Company of a copy of irrevocable and unconditional instructions, satisfactory in form and substance to the Company, to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/mevion-medical-systems-inc-23483/contract/407843/#clause-id-874428", "variations": []}
{"clause_number": "Clause 47", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. If an Exercise Notice is delivered at a time when a registration statement permitting the Holder to resell the Warrant Shares is not then effective or the prospectus forming a part thereof is not then available to the Holder for the resale of the Warrant Shares, then the Holder may notify the Company in an Exercise Notice of its election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant Shares determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. A = the average of the closing prices for the five Trading Days immediately prior to (but not including) the Exercise Date. B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued. 8 11. Limitations on Exercise. Notwithstanding anything to the contrary contained herein, the number of Warrant Shares that may be acquired by the Holder upon any exercise of this Warrant (or otherwise in respect hereof) shall be limited to the extent necessary to insure that, following such exercise (or other issuance), the total number of shares of Common Stock then beneficially owned by such Holder and its Affiliates and any other persons whose beneficial ownership of Common Stock would be aggregated with the Holder's for purposes of Section 13(d) of the Exchange Act, does not exceed 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant (the \"Beneficial Ownership Limitation\"). The Holder, upon not less than 61 days' prior notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 11, provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 11 shall continue to apply. Any such increase or decrease will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 11 to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant. For such purposes, beneficial ownership shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. This provision shall not restrict the number of shares of Common Stock which a Holder may receive or beneficially own in order to determine the amount of securities or other consideration that such Holder may receive in the event of a Fundamental Transaction as contemplated in Section 9(b) of this Warrant. The holders of Common Stock shall be third party beneficiaries of this paragraph and the Company may not waive this paragraph without the consent of holders of a majority of its Common Stock.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/electronic-cigarettes-international-group-ltd-18588/contract/408698/#clause-id-876956", "variations": []}
{"clause_number": "Clause 48", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. (a) Payment Options. The exercise price shall be paid by one or any combination of the following forms of payment that are applicable to this option, as indicated on the cover page hereof: (i) by check payable to the order of the Company; or (ii) delivery of an irrevocable and unconditional undertaking, satisfactory in form and substance to the Company, by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price, or delivery by the Optionee to the Company of a copy of irrevocable and unconditional instructions, satisfactory in form and substance to the Company, to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price; or (iii) subject to Section 7(b) below, if the Common Stock is then traded on a national securities exchange or on the Nasdaq National Market (or successor trading system), by delivery of shares of Common Stock having a fair market value equal as of the date of exercise to the exercise price. 4 In the case of (iii) above, fair market value as of the date of exercise shall be determined as of the last business day for which such prices or quotes are available prior to the date of exercise and shall mean (i) the last reported sale price (on that date) of the Common Stock on the principal national securities exchange on which the Common Stock is traded, if the Common Stock is then traded on a national securities exchange; or (ii) the last reported sale price (on that date) of the Common Stock on the Nasdaq National Market (or successor trading system), if the Common Stock is not then traded on a national securities exchange. (b) Limitations on Payment by Delivery of Common Stock. If Section 7(a)(iii) is applicable, and if the Optionee delivers Common Stock held by the Optionee (\"Old Stock\") to the Company in full or partial payment of the exercise price and the Old Stock so delivered is subject to restrictions or limitations imposed by agreement between the Optionee and the Company, an equivalent number of Shares shall be subject to all restrictions and limitations applicable to the Old Stock to the extent that the Optionee paid for the Shares by delivery of Old Stock, in addition to any restrictions or limitations imposed by this agreement. Notwithstanding the foregoing, the Optionee may not pay any part of the exercise price hereof by transferring Common Stock to the Company unless such Common Stock has been owned by the Optionee free of any substantial risk of forfeiture for at least six months.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/marinus-pharmaceuticals-inc-2553/contract/411441/#clause-id-884292", "variations": []}
{"clause_number": "Clause 49", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. Except in the case of a Cashless Exercise pursuant to subsection 4(b) above, the Holder shall pay the Aggregate Exercise Price by paying, in lawful money of the United States, by certified check payable to the Warrant Agent, as agent for the Company, or bank draft payable to the order of the Company or by wire transfer of immediately available funds to an account designated in writing by the Company (or as otherwise agreed to by the Company) delivered to the Warrant Agent not later than one Trading Day after the Date of Exercise.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/dnib-unwind-inc-9259/contract/414304/#clause-id-892589", "variations": []}
{"clause_number": "Clause 50", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. The Holder may pay the Exercise Price in one of the following manners: (a) Cash Exercise. The Holder may deliver immediately available funds; or (b) Cashless Exercise. If on the Date of Exercise there is no effective registration statement registering, or the prospectus contained therein is not available for, the resale of the Warrant Shares, the Holder may notify the Company in an Exercise Notice of its election to utilize cashless exercise, in which event the Company shall issue to the Holderthe number of Warrant Shares determined as follows: X = Y [(A-B)/A] where: X = the number of Warrant Shares to be issued to the Holder. Y = the number of Warrant Shares with respect to which this Warrant is being exercised. -7- A = the average of the daily volume weighted average price of the Common Stock for the five Trading Days immediately prior to (but not including) the Date of Exercise. B = the Exercise Price. For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/soleno-therapeutics-inc-3774/contract/421686/#clause-id-914831", "variations": []}
{"clause_number": "Clause 51", "title": "Payment of Exercise Price", "text": "Payment of Exercise Price. Payment of the Option exercise price must be made in full pursuant to any of the following procedures or such other electronic or other procedures as may be specified by the Committee or its plan administrator from time to time: (i) in cash, by check or cash equivalent, (ii) by delivery to the Corporation of 11 unencumbered shares of Common Stock owned by the Participant having a Fair Market Value not less than the exercise price, (iii) by attestation to the Corporation by the Participant of ownership of shares of Common Stock having a Fair Market Value not less than the exercise price accompanied by a request and authorization to the Corporation to deliver to the Participant upon exercise only the number of whole shares by which the number of shares covered by the Option being exercised exceeds the number of shares stated in such attestation; (iv) by delivery to the Corporation by a broker of cash equal to the exercise price of the Option upon an undertaking by the Participant to cause the Corporation to deliver to the broker some or all of the shares being acquired upon the exercise of the Option (a \"Cashless Exercise\"), (v) by a \"net exercise\" arrangement pursuant to which the Corporation will reduce the number of shares of Common Stock issued upon exercise of the Option by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price and the Participant shall deliver to the Corporation a cash or other payment to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of whole shares to be issued; (vi) by such other consideration as may be approved by the Committee from time to time to the extent permitted by applicable law, or (vii) by any combination of the foregoing. The Committee may at any time or from time to time grant Options which permit only some of the foregoing forms of consideration to be used in payment of the exercise price or which otherwise restrict the use of one or more forms of consideration. Any shares transferred to the Corporation will be added to the Corporation's treasury shares or canceled and become authorized and unissued shares of Common Stock but such shares shall not increase the shares reserved for issuance under the Plan in Paragraph 5(a) above. The number of shares of Common Stock covered by, and available for exercise under, a Participant's Options shall be reduced by (A) shares covered by an attestation used for netting in accordance with clause (iii) above; (B) shares used to pay the exercise price pursuant to a \"net exercise\" in accordance with clause (v) above; (C) shares delivered to the Participant as a result of any exercise, and (D) shares withheld to satisfy tax withholding obligations.", "found_in": "https://contracts.justia.comhttps://contracts.justia.com/companies/knowles-corporation-765/contract/433399/#clause-id-948923", "variations": []}
